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ABSTRACT 
The effects of a multiple step antioxidant nutritional supplementation  




PURPOSE:  To determine if 5 days of antioxidant supplementation coupled with a pre-
ride antioxidant/energy supplement improves cycling performance or reduces oxidative 
stress in trained cyclists. 
 
METHODS:  Eight well-trained cyclists participated in a double-blind cross-over 
placebo-controlled study.  Maximal oxygen consumption (VO2Max), peak power output 
(WMax) and total work during a 15-minute time trial were determined.  Subjects 
consumed an antioxidant supplement (S) or a placebo (P) for 5 days before each trial and 
a pre-exercise supplement or isocaloric placebo (4 kcal·kg-1) 45 minutes before each trial.  
Subjects performed an endurance ride of 90 minutes followed immediately by a time trial 
requiring accumulation of total work equal to the initial time trial. 
 
RESULTS:  The GSH:GSSG ratio remained constant prior to both experimental trials, 
while  resting total GSH concentrations exhibited a main effect (p = 0.038) in response to 
step-one of the supplement protocol for basal (S: 1020.2 ± 135.8 µmol·L-1; P: 1000.2 ± 
252.9 µmol·L-1) vs. pre-endurance (S: 979.2 ± 155.1 µmol·L-1; P: 867.3 ± 231.2 µmol·L-
1).  During the endurance ride, no differences were observed in average power (S: 224.0 ± 
36.5 W; P: 219.1 ± 19.2 W), oxygen consumption (S: 2.8 ± 0.4 L·min-1; P: 2.8 ± 0.4 
L·min-1), heart rate (S: 148.4 ± 3.5 beats·min-1; P: 146.3 ± 4.5 beats·min-1), or 
GSH:GSSG ratio (S: 1.4 ± 0.7; P: 1.4 ± 0.9).  During the time trial tests, supplementation 
did not lead to any differences between average power (S: 303.6 ± 59.2 W; P: 306.1 ± 
47.0 W), oxygen consumption (S: 3.5 ± 0.4 L·min-1; P: 3.3 ± 0.6 L·min-1), heart rate (S: 
171.1 ± 6.5 beats·min-1; P: 170.3 ± 3.5 beats·min-1), or GSH:GSSG ratio (S: 1.1 ± 0.6; P: 
0.9 ± 0.7). 
 
CONCLUSION:  Consuming an antioxidant supplement for 5 days coupled with a pre-
exercise antioxidant/energy supplement does not result in significant improvements in 
cycling performance.  However, the multiple-step supplementation may attenuate 
oxidative stress during the cycling bout when compared to a placebo, possibly due to the 
maintenance of glutathione levels. 
 ii
Table of Contents 
 
Section                                                                                                                            page 
Table of Contents ............................................................................................................... iii 
List of Tables ..................................................................................................................... vi 
List of Figures ................................................................................................................... vii 
Chapter 1.  Introduction ...................................................................................................... 1 
1.1. Purpose & Specific Aims ......................................................................................... 1 
1.1.1. Purpose .............................................................................................................. 1 
1.1.2. Central Hypothesis ............................................................................................ 2 
1.1.3. Specific Aim 1 .................................................................................................. 3 
1.1.4. Specific Aim 2 .................................................................................................. 4 
1.1.5. Specific Aim 3 .................................................................................................. 5 
1.1.6. Specific Aim 4 .................................................................................................. 6 
1.2. Background & Significance ..................................................................................... 7 
1.3. Limitations of Study .............................................................................................. 11 
1.4. Operational Definitions .......................................................................................... 12 
Chapter 2.  Review of Literature ....................................................................................... 16 
2.1. Introduction ............................................................................................................ 16 
2.2. Free Radicals, Oxygen Radicals, and Nitrogen Radicals ...................................... 16 
2.3. Production of Reactive Oxygen and Nitrogen Species during Exercise ................ 18 
2.3.1. Reactive Oxygen Species Production ............................................................. 18 
2.3.2. Reactive Nitrogen Species Production During Exercise/ Interaction with 
Reactive Oxygen Species .......................................................................................... 19 
 iii
2.4. Determining Reactive Oxygen and Nitrogen production during exercise ............. 19 
2.5. Antioxidants Fluctuations, Cell Damage, and Oxidative Stress ............................ 21 
2.5.1. Non-Enzymatic Antioxidants: Ascorbic Acid and α –Tocopherol ................. 22 
2.5.2. Non-Enzymatic Antioxidant: Glutathione ...................................................... 24 
2.5.3. Glutathione and Cycling ................................................................................. 25 
2.5.4. Glutathione’s Synergistic Effect ..................................................................... 27 
2.6. Reactive Oxygen and Nitrogen Species and Signal Transduction ......................... 27 
2.7. Efficacy of antioxidant supplementation ............................................................... 29 
2.8. Antioxidant and Energy Substrate Supplementation ............................................. 30 
2.9. Cycling Performance ............................................................................................. 34 
2.10. Appropriate protocol for examining nutritional intervention .............................. 36 
2.11. Limitations in Current Supplement Research ...................................................... 38 
2.12 References ............................................................................................................. 40 
Chapter 3 ........................................................................................................................... 54 
REFERENCES ................................................................................................................. 80 
Figure Captions ................................................................................................................. 95 
Appendix A: IRB ............................................................................................................ 103 
Appendix B: Informed Consent ...................................................................................... 107 
Appendix C: Health History Questionnaire .................................................................... 112 
Appendix D: Eligibility Questionnaire ........................................................................... 115 
Appendix E: Relevant Supplementation Studies ............................................................ 117 
Appendix F: Raw Data.................................................................................................... 121 
F.1. Biometrics Data Table ......................................................................................... 122 
 iv
F.2. VO2max Testing Data Table .................................................................................. 123 
F.3. Performance Data Tables ..................................................................................... 124 
F.4. Lactate Data Table ............................................................................................... 134 
F.5. Glucose Data Table.............................................................................................. 135 
F.6. Total Body Fuel Oxidation Tables ...................................................................... 136 
F.7. Glutathione Data Tables ...................................................................................... 138 
F.8. Nitrotyrosine Data Table ..................................................................................... 144 
F.9. Dietary Consumption Data Table ........................................................................ 145 
 
 v
List of Tables 
 
Table 1. Subject Characteristics ........................................................................................ 90 
Table 2. Step-One Treatment Ingredients ......................................................................... 91 
Table 3. Step-One and Step-Two Placebo Ingredients ..................................................... 92 
Table 4. Step-Two Treatment Ingredients ........................................................................ 93 



















List of Figures 
 
Figure 1. Experimental Approach ..................................................................................... 96 
Figure 2. Time Trial Time ................................................................................................ 97 
Figure 3. Relative Average Power .................................................................................... 98 
Figure 4. Endurance Ride Economy ................................................................................. 99 
Figure 5. Time Trial Economy........................................................................................ 100 
Figure 6. Lactate ............................................................................................................. 101 
Figure 7. Glutathione ...................................................................................................... 102 
 
Chapter 1.  Introduction 
1.1. Purpose & Specific Aims 
1.1.1. Purpose 
     The ability to perform high intensity aerobic endurance activity requires a significant increase 
in oxygen consumption (VO2) and is clearly demonstrated by the linear increase in VO2 which 
occurs as intensity increases during a graded cycle ergometry test.81  In order to meet the work 
demand, a constant supply of energy to the working muscles must be provided to maintain 
performance during high intensity aerobic exercise.59, 72  These activities can result in 
accumulation of reactive oxygen species,39 oxidative stress,64 and oxidative muscle damage42, 100  
due to increased radical production associated with increased oxygen consumption.63  Recent 
studies have examined the effect of various dietary supplements on their ability to enhance 
endurance performance,81 alter fuel metabolism,36, 86 decrease markers of oxidative stress,82, 108 
and decrease markers of post-exercise muscle damage.42, 97  These dietary supplements include 
carbohydrate,59, 72 protein,79, 110, 122 arginine,1, 86 carnitine,12 aspartate,1 tartrate,12 vitamins A, C, 
and E,2, 19, 20, 82, 93, 113 selenium,97, 118 allopurinol,42 Siberian ginseng,30 and reduced glutathione.108 
Most of these supplements have required long-term (~ 4 weeks) use to provide the desired 
effects,2, 20, 42, 81 and most have been studied independently of one another.19, 42, 86, 93, 118  It has 
been suggested that because most of these supplements work synergistically, they should be 
consumed in combination as an antioxidant energy substrate cocktail, rather than 
independently.112  Thus, supplementation with antioxidant energy substrate cocktails has also 
been evaluated in regards to providing ergogenic effects.81, 119   
     There is evidence that consumption of antioxidant energy substrate cocktails increase 
endurance performance,81 but no underlying mechanisms have been identified.  In addition, 
recent research has suggested that long-term supplementation could be detrimental to cellular 
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adaptations that lead to improvements in endurance capacity.41  Thus, short-term antioxidant 
supplementation could lead to improvements in performance without interrupting cellular 
adaptations that occur as a result of training.  Therefore, the purpose of this project was to 
determine if a multiple step antioxidant nutritional supplement protocol which includes a 5 day 
antioxidant cocktail loading phase coupled with a pre-event antioxidant/energy beverage 
increases performance, reduces markers of oxidative stress, or enhances fuel metabolism during 
a high-intensity cycle ergometry exercise test in trained competitive cyclists. 
1.1.2. Central Hypothesis 
     This study examined the effects of a short-term multiple step antioxidant nutritional 
supplement protocol in high-intensity cycling.  The central hypothesis was that a multiple step 
antioxidant nutritional supplement protocol would result in increased cycling performance via 
enhancement of fuel metabolism and by reducing levels of oxidative stress.  This central 
hypothesis was tested by addressing the following four specific aims. 
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1.1.3. Specific Aim 1 
     The first aim was to determine whether supplementation would alter cycling performance in 
trained male cyclists when compared to a multiple step isocaloric placebo.  The aim was 
examined by determining the amount of time to achieve a pre-determined amount of work, the 
average power output, and oxygen consumption during a validated repeated measure cycle 
ergometry test (preload+time trial). 
Hypothesis 1:   
A multiple step antioxidant nutritional supplement protocol would result in a decreased 
time to complete the set amount of work during the time trial, an increase in average 
power output per given average heart rate and a decrease in relative oxygen consumption 
per given power output during the cycle ergometry test at 30 min, 60 min, and 90 min of 
the preload and throughout the time trial when compared with a placebo protocol. 
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1.1.4. Specific Aim 2 
     The second aim was to determine whether a five day loading phase of an all-natural 
antioxidant supplement during a summer cycling competition phase alters the basal level of 
indicators of oxidative stress when compared to a placebo loading phase.  The aim was examined 
by determining the basal concentration of whole blood reduced glutathione, the ratio of whole 
blood reduced glutathione/oxidized glutathione, and the concentration of plasma nitrotyrosine. 
Hypothesis 2:   
The antioxidant loading phase would result in an increase in the basal whole blood 
concentrations of reduced glutathione, an increase in the basal whole blood reduced 
glutathione/oxidized glutathione ratio, and a decrease in the basal concentration of 
plasma nitrotyrosine as compared with a  placebo protocol. 
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1.1.5. Specific Aim 3 
     The third aim was to determine whether supplementation would alter the exercise-induced 
acute oxidative stress in response to a high intensity cycling time trial after the performance of 
90 minutes of cycling.  The aim was addressed by examining the immediate post-exercise 
concentration of whole blood reduced glutathione, the ratio of whole blood reduced 
glutathione/oxidized glutathione ratio, and the concentration of plasma nitrotyrosine. 
 
Hypothesis 3:   
A multiple step antioxidant nutritional supplement protocol would result in the 
attenuation of the decrease in whole blood reduced glutathione and the reduced 
glutathione/oxidized glutathione ratio and the attenuation of the increase in plasma 
nitrotyrosine that may occur in response to the cycle ergometry test as compared with a 
placebo protocol. 
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1.1.6. Specific Aim 4 
     The fourth aim was to determine whether supplementation would alter fuel metabolism in 
trained male cyclists when compared to a multiple step isocaloric placebo.  The aim was 
examined by determining the concentration of plasma glucose, whole blood lactate production, 
respiratory exchange ratio, and whole-body rates of fat and carbohydrate oxidation calculated 
from the nonprotein respiratory exchange ratio during a validated repeated measure cycle 
ergometry test. 
Hypothesis 4: 
A multiple step antioxidant nutritional supplement protocol would result in the 
attenuation of the decrease in plasma glucose concentration and carbohydrate oxidation, 
attenuation of the increase in whole blood lactate concentration, respiratory exchange 
ratio, and fat oxidation during the cycle ergometry test as compared with a placebo 
protocol. 
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1.2. Background & Significance 
     Exercise results in an increased metabolic rate, which is associated with an increase in oxygen 
consumption in the exercising tissues.63  Cycling is a mode of exercise that results in significant 
increases in oxygen consumption as intensity increases49 and requires the athlete to maintain 
high performance intensities for prolonged durations during competition.31  This fact is best 
represented by the analysis of an individual time trial where competitive cyclists spend an 
average of 20 minutes at >90% maximal oxygen consumption (VO2max).31  Additionally, it has 
been reported that the winner of an individual time trial during the Tour de France cycled at 
>90% VO2max for 70 minutes.77  The constant demand for energy is supplied to the working 
muscle by the mitochondria, where oxygen is the final electron acceptor.63 The catabolic 
processes in the mitochondria result in the formation of free radicals and other reactive oxygen 
species,44 which subsequently leads to the formation of reactive nitrogen species.84  Metabolic 
processes that occur during cycling intensities of ≥75% VO2max result in high rates of 
carbohydrate oxidation, and supplementation with carbohydrate during an hour of cycling at 
75% VO2max has resulted in a 2.3% increase in performance, determined by a decreased time 
during a time trial.56  This increase in performance is considered an ergogenic benefit which is 
stimulated by carbohydrate supplementation. 
     An ergogenic aid, such as energy substrates found in dietary supplements, generally result in 
performance improvements during endurance exercise.5  The use of ergogenic aids has been 
documented since ancient times.6  Current ergogenic aids include: energy sources, such as 
carbohydrate; anabolic enhancers, such as protein and amino acids; and dietary antioxidant 
cocktails.5, 81, 119  Antioxidants are substances that quench free radicals and reactive oxygen and 
nitrogen species, thereby reducing the severity of oxidative stress.38  Oxidative stress occurs as a 
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result of an imbalance between reactive oxygen and nitrogen species and the antioxidant defense 
system.63  During high-intensity exercise, such as an individual time trial, the accumulation of 
reactive oxygen and nitrogen species can occur.39 
     The accumulation of reactive oxygen and nitrogen species during a state of oxidative stress 
can lead to oxidative injury during and after acute bouts of strenuous exercise,63 such as intense 
aerobic exercise.5  Oxidative injuries can include lipid peroxidation18,18 and protein 
oxidation,13,78,10 which may lead to oxidative muscle damage61 that can contribute to altered 
cellular integrity and muscle metabolism and result in impaired muscular performance.70  
Markers of muscle damage are routinely increased after prolonged high-intensity cycling.42,109,110  
Furthermore, the red blood cell is also susceptible to  oxidative damage.75, 79  Thus, when the 
antioxidant defense system is inadequate and reactive oxygen and nitrogen species are not 
controlled, accumulating levels of reactive oxygen and nitrogen species can result in oxidative 
damage that could result in a chronic decrease in endurance performance due to muscle tissue 
loss and decreased capacity to transport oxygen.  The accumulation of oxidative damage is 
relative to the production of reactive oxygen and nitrogen species63 and the collective success of 
the antioxidant defense and muscle repair systems.65   
     The antioxidant defense system encompasses both nonezymatic and enzymatic antioxidants.  
The nonenzymatic antioxidants include the exogenous antioxidant vitamins and endogenous 
glutathione.  The antioxidant vitamins are considered non-inducible antioxidants, meaning that 
their concentrations are not altered with training adaptations.63  Inducible antioxidants respond to 
training by adapting to quench higher levels of reactive oxygen and nitrogen species.  Inducible 
antioxidants include the enzymatic antioxidants and the glutathione antioxidant system.63  
Enzymatic antioxidants superoxide dismutase and glutathione peroxidase have been shown to 
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have increased activity levels after controlled endurance training.89  It is relevant to mention that 
glutathione and Vitamins C and E are synergistic in their actions, meaning that these antioxidants 
work together to neutralize reactive oxygen species.33, 53   This indicates that alterations in one of 
these antioxidants can have an effect on the others (i.e. the use of α –tocopherol  can compensate 
for inadequacies in the glutathione antioxidant system).  The only way to alter the antioxidant 
vitamin concentrations is through modulation of dietary intake or dietary supplementation.63  
Dietary antioxidants are susceptible to deficiency,63 and it is not uncommon for competitive 
endurance athletes such as cyclists to have an inadequate dietary intake of antioxidants and 
calories 78, 80 due to high caloric expenditure during training and competition.  Furthermore, 
many cyclists attempt to reduce body weight which may contribute to the effects stimulated by 
an inadequate dietary intake.  This maintenance of low body weight could create a scenario of 
inadequate exogenous antioxidant intake.  Based upon this line of reasoning it appears that 
antioxidant supplementation could be beneficial for the maintenance of the exogenous 
antioxidant system in these types of situations.   
     A few studies have investigated the effect of short term (≤14 days) antioxidant 
supplementation on oxidative stress and performance.120,47,7  The supplementation protocols 
varied in timing from 2 hours7 to 14 days47 prior to exercise.  A graded cycling max test coupled 
with ascorbic acid supplementation taken 2 hours prior to the high intensity aerobic exercise bout 
was evaluated.7  Results indicated an increase in plasma ascorbic acid levels and a decrease in 
oxidative stress at rest and in response to the exercise in healthy untrained subjects.7  This 
indicates that short-term supplementation maybe beneficial in reducing oxidative stress by 
attenuating uncontrolled production of reactive oxygen and nitrogen species that can lead to an 
oxidative stress condition.  Uncontrolled levels of reactive oxygen and nitrogen species during 
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oxidative stress can result in oxidative damage which could lead to decreases in high intensity 
aerobic exercise performance of longer duration or in subsequent performances during a 
competitive season.  An antioxidant energy substrate cocktail may provide increased levels of 
protection beyond that of independently supplementing with only ascorbic acid, but there 
currently exists no scientific literature evaluating this concept.  Thus, more research on the 
effects of short term antioxidant cocktail supplementation protocols on cycling performance in 
trained athletes is warranted.   
     Exogenous antioxidant supplementation for 6 weeks has lead to improvements in cycling 
performance during a laboratory time trial.81  However, it has recently been suggested that long-
term antioxidant supplementation may be detrimental to cellular adaptations that lead to 
improvements in endurance capacity.31  A number of cellular signaling pathways respond to 
reactive oxygen and nitrogen species, which ultimately contributes to improvements in 
endurance performance.65  So, the efficacy of long-term or chronic antioxidant supplementation 
is currently being questioned in the scientific literature.65   
     It has also been speculated that long-term or chronic antioxidant supplementation could 
prevent desirable adaptations in inducible antioxidants, limiting the adaptive capacity to deal 
with reactive oxygen and nitrogen species.65  However, this may not occur in all situations.  For 
example, if an athlete has inadequate nutrient intake, the inclusion of an antioxidant 
supplementation protocol may be warranted as it likely will attenuate oxidative stress-associated 
muscle damage that can occur in athletes with low exogenous antioxidant intake during 
simulated competitions,97 high intensity training, or during actual competitive events.  
     Regardless of exogenous antioxidant status, supplementation with dietary antioxidants 
routinely results in decreased muscle damage in response to strenuous cycling in trained 
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cyclists.42, 109, 110  This attenuation of muscle damage results in decreased muscular fatigue and 
could preserve performance in times of intense competition, during periods of intensified 
training such as overreaching, or at the onset of overtraining syndrome.33  Therefore, the timing 
of antioxidant supplementation seems to be essential for allowing reactive oxygen and nitrogen 
signaling to facilitate training adaptations, but high concentrations of reactive oxygen and 
nitrogen generated during competition and during periods of overreaching must be controlled to 
eliminate the possibility of the development of a chronic oxidative stress condition that would 
result in detriments to performance.33   
1.3. Limitations of Study 
     There were limitations within the implementation of this study.  The ability to control for the 
cyclists’ nutritional intake and training was limited.  A dietary and training recall provided some 
level of control, but this is only if the subjects took this practice seriously and accurately 
recorded dietary intake and training rides.  The consumption of foods and consistent training 
without documentation into the supplied logs could have taken place and could be a confounding 
variable.  The lack of consumption of the desired dose of capsules during the loading phase 
treatment period could further confound the results.  The consumption of a single dose of the 
antioxidant/energy substrate during step-two of the supplementation protocol may not be 
adequate; it is possible that multiple daily doses prior to training could produce superior results.  
Furthermore, a placebo effect could have resulted if subjects believed that they had the treatment 
during the placebo trial.  If the cyclist believed he was on the supplement, the level of motivation 
may have been increased.  This would have been due to expectations that the supplement 
improves performance.  Such motivational factors could indeed lead to false performance 
improvements. The cyclists were also provided with data during the experimental trials and as a 
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pacing strategy they may attempt to reproduce levels of the same power or heart rate values 
during the experimental time trial, which could have resulted in similar performances.  Some 
basic assumptions include that the athletes gave a maximal effort throughout all testing 
procedures and that they were unaware of the treatment given. 
1.4. Operational Definitions 
Antioxidant:  Antioxidants are substances that quench free radicals and reactive oxygen and 
nitrogen species thereby reducing the severity of oxidative stress.13, 27, 38 
Dietary Antioxidant:  A dietary antioxidant is a substance gained from food that may assist in 
reducing the concentration of oxidative species and the muscle damage caused by free radicals 
and reactive oxygen and nitrogen and has also been used as a therapeutic agent for muscle repair 
processes during recovery.39 
Endogenous Antioxidant:  An endogenous antioxidant is a tissue antioxidant enzyme that is 
important in the protection of cells against free-radical-mediated damage.  The primary 
antioxidant enzymes include superoxide dismutase, catalase, glutathione peroxidase, and 
glutathione reductase.  These enzymes are also referred to as the oxygen radical scavenger 
enzymes.39 
Exogenous Antioxidant:  Exogenous antioxidants are dietary antioxidants that must be obtained 
through the diet or dietary supplements.63 
Ergogenic Aid:  An ergogenic aid, such as a dietary supplement, results in performance 
improvements.6 
Free Radical:  A free radical is a chemical species that contains at least one unpaired electron 
and is produced in all living cells.15, 27 
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Glutathione Peroxidase: Glutathione peroxidase is the enzyme that uses reduced glutathione to 
reduce hydrogen peroxide resulting in the formation of oxidized glutathione.87 
Glutathione Reductase: Glutathione reductase is the enzyme that uses ß–nicotinamide adenine 
dinucleotide phosphate to convert oxidized glutathione back into reduced glutathione.87 
Isocaloric:  Isocaloric means equating caloric content of two different supplement treatments 
though the concentration of macronutrients is not the same (i.e. a carbohydrate+protein beverage 
(200 kilocalories) and a carbohydrate-only beverage (200 kilocalories)).105 
Lipid Peroxidation:  Lipid peroxidation is the process of oxidizing fatty-acid side chains found in 
membrane lipids to hydroperoxides; membrane lipids that contain two or more carbon-carbon 
double bonds, a.k.a. polyunsaturated, have increased susceptibility to oxidation.45  
Oxidation: Oxidation is the process of gaining oxygen or donating electrons (e.g. in the situation 
of hydrogen peroxide formation where H2 reacts with O22-, the H2 is said to have undergone 
oxidation because it donates electrons to O22- resulting in the formation of hydrogen peroxide).  
In this reaction, H2 gains the oxygen.85 
Oxidative stress: Oxidative stress occurs as a result of an imbalance between reactive oxygen 
and nitrogen and the antioxidant defense system.  Oxidative stress can result due insufficient 
quenching of reactive oxygen and nitrogen by antioxidants, an overproduction of reactive 
oxygen and nitrogen, or a drop in antioxidant defenses. Exercise is known to stimulate oxidative 
stress.15, 27, 52, 53 
Oxidized Glutathione (Glutathione Disulfide): Oxidized glutathione is produced during the 
reactions of reduced glutathione with hydrogen peroxide.87  Oxidized glutathione is routinely 
found to increase in response to exercise-induced oxidative stress.111 
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Protein Oxidation: Protein oxidation is the process where cellular proteins are altered by reactive 
oxygen and nitrogen species primarily at peptide bonds or amino acid side chains, leading to the 
loss of catalytic or structural functions and leaving the protein highly susceptible to proteolytic 
degradation.27 
Reactive Nitrogen Species: Reactive nitrogen species include free radicals that are nitrogen bases 
(e.g. nitric oxide (NO·), nitrogen dioxide (NO2·), and peroxynitrite (ONOO-)).15 
Reactive Oxygen Species:  Reactive oxygen species include free radicals that are oxygen based 
(e.g. superoxide (O2·-), hydroxyl (OH·), alkoxyl (RO·), peroxyl (ROO·), and hydrogen peroxyl 
(ROOH·)) and non-radicals such as hydrogen peroxide.15 
Reduction: Reduction is the process of losing oxygen or accepting electrons (e.g. in the situation 
of hydrogen peroxide formation where H2 reacts with the peroxide ion (O22-), the O22- is said to 
have undergone reduction because it accepts electrons as it reacts with H2 resulting in the 
formation of hydrogen peroxide). In this reaction molecular oxygen is lost in the formation of 
molecular hydrogen peroxide.85 
Reduced Glutathione: Reduced glutathione (γ-glutamylcysteinylglycine) is the most important 
nonenzymatic antioxidant found in erythrocytes; reduced glutathione serves as substrate for 
glutathione peroxidase and also directly quenches singlet oxygen and hydrogen peroxide.62, 87 
Time Trial: A time trial in competitive cycling is either an individual or team event in which a 
specific distance is covered as fast as possible.57  Laboratory time trials are endurance 
performance tests with a known end point, such as a target amount of work or time, give the 
subject control of resistance and pedal cadence, and are highly reproducible.58 
Maximal oxygen uptake:  Maximal oxygen uptake (VO2max) is a physiological characteristic that 
is bound by the parametric limits of the Fick equation [(left ventricular end-diastolic volume) – 
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(left ventricular end-systolic volume) x heart rate x arterio-venous oxygen difference] and is 
continually found to be high in endurance athletes, most likely due to a high cardiac output, but 
is not necessarily indicative of endurance athletic performance.75 
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Chapter 2.  Review of Literature 
2.1. Introduction 
     Competitive endurance athletes routinely engage in strenuous exercise during competition31 
that results in increases in oxygen consumption,81 increases in free radical associated damage,76 
and disruption of the oxidant/antioxidant balance.64  This disruption favors the production of 
oxidants, such as reactive oxygen and nitrogen species, which challenge the cellular antioxidant 
defense system.33, 99  If the antioxidant defense system is inadequate or the exercise intensity or 
duration is extreme, depletion of antioxidants can occur leaving reactive oxygen and nitrogen 
species biologically active to react with cellular tissues and resulting in a situation known as 
oxidative stress.15  Exercise increases metabolism and subsequently results in increased levels of 
free radical and reactive oxygen and nitrogen species.32  Unrepressed reactive oxygen and 
nitrogen species can result in cellular oxidative stress in which tissues are susceptible to 
oxidative damage.63, 102 
2.2. Free Radicals, Oxygen Radicals, and Nitrogen Radicals 
    During resting conditions the oxygen content in arterial and venous blood of skeletal muscle 
tissue is 20 and 15 ml per 100 ml of blood, respectively; during exercise of an aerobic nature, 
skeletal muscle arterial-venous oxygen differences increases by 3-fold, and skeletal muscle blood 
flow increases by 30-fold.111  This large increase of blood flow during aerobic exercise is 
necessary to support the increase in oxygen metabolism, as indicated by the arterial-venous 
oxygen difference, due to increased energy consumption in the working skeletal tissue.  Oxygen 
radicals can be produced from the metabolism of oxygen during energy production.63  When a 
biomolecule undergoes oxidation, it accepts an electron and is then considered to be oxidized.  If 
the electron is unpaired, the biomolecule is considered to be a free radical.  According to Pauli’s 
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principle, electrons should be accepted in anti-parallel fashion. Since the biomolecule dioxygen 
already contains two unpaired electrons in a different anti-bonding orbital, the electrons being 
accepted must have parallel spin to fit into the vacant orbital spaces.  This imposes a restriction 
on dioxygen and causes it to routinely accept only one electron at a time, resulting in formation 
of the superoxide radical.46    
     The addition of a second electron to the superoxide radical results in the formation of a 
peroxide ion, which is not a free radical because it contains no unpaired electrons.46  This 
biomolecule is protonated immediately at physiological pH, resulting in the formation of 
hydrogen peroxide.46  Like a peroxide ion, hydrogen peroxide cannot be considered a free radical 
because it does not host an unpaired electron, but it can be considered a reactive oxygen species 
because of its capacity to generate reactive oxygen species.33  For example, one product from 
Fenton’s reaction between hydrogen peroxide and ferrous ion is a hydroxyl radical, which reacts 
with tissues causing the oxidation of membrane lipids, termed lipid peroxidation, and protein 
oxidation.74 
     Reactive oxygen species are not the only biomolecules that interact with tissues causing lipid 
peroxidation and protein oxidation.  Nitrogen radicals form when reactive oxygen species 
interact with nitric oxide to produce reactive nitrogen species.123  Reactive nitrogen species 
include nitrogen dioxide, and peroxynitrite.  Reactive nitrogen species also react with 
biomolecules, causing lipid peroxidation126 and premature protein degradation due to 
nitrosylation.115  Thus, when reactive oxygen species accumulate there is a greater chance in the 
formation of reactive nitrogen species.   
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2.3. Production of Reactive Oxygen and Nitrogen Species during Exercise 
     Healthy resting muscle produces low amounts of reactive oxygen species,91 which is easily 
handled by the antioxidant system.33  However, in conditions of disease and chronic stress, such 
as exercise, the antioxidant system can become overwhelmed by the accumulation of reactive 
oxygen species, leading to cellular damage.33  This damage may occur as a result of the oxidation 
of membrane lipids45 and proteins,115 which increases in exercising muscle due to the increases 
in free radicals.18  If the damage is excessive, a loss of muscle function may occur.91  
Mitochondria are known to be a significant source of reactive oxygen species in working muscle 
tissue during exercise.21   Other sources of reactive oxygen species due to oxidation include 
myoglobin and hemoglobin.125  In addition to reactive oxygen species, reactive nitrogen species 
are also produced during exercise.40 
2.3.1. Reactive Oxygen Species Production 
     It is postulated that the increase in oxygen demand of the skeletal muscle during acute bouts 
of aerobic exercise results in increased concentration of superoxide.39  Intense physical exercise 
results in increased free radical production from the muscle mitochondria,74 which is mostly due 
to increased oxygen flux through the electron transport chain.63  Reactive oxygen species 
formation has been found to be proportional to electron transport chain activity.21  Generally 
oxygen is the final acceptor of two electrons at the end of the electron transport chain and 95-
99% of the time is reduced to water.32  However, it actually prefers to receive one electron at a 
time, due to Pauli’s principle requiring the incoming electrons to have parallel spin.46  Thus, the 
remaining 1-5% oxygen  receives only one electron,54 leading to the generation of a superoxide 
radical55 at complex I and III90 which may result in damage to the mitochondria.35, 74  This 
mitochondrial damage can then cause alterations in the function of the electron transport chain35 
and increased oxygen loss.53  Mitochondrial damage can lead to further reactive oxygen species 
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production and additional mitochondrial damage, which can contribute to an energetic decline35 
as a result of the mitochondria no longer being able efficiently  produce ATP due to oxygen loss.  
It is proposed that during exhaustive exercise, mitochondrial disruption can lead to a further loss 
of cell function, cell necrosis, muscle damage, and inflammation.30, 59, 19 
     The oxidation of hemoglobin can also be a source of reactive oxygen species; about 3% of 
total hemoglobin undergoes auto-oxidation, resulting in the formation of superoxide.52  The 
oxidation of the red blood cell is of particular interest due to their concentration of 
polyunsaturated fatty acids and heme iron, which makes erythrocytes particularly susceptible to 
oxidative damage.113 Myoglobin is susceptible to both free radical oxidation and auto-
oxidation.125  Auto-oxidation occurs when ferrous iron, present in myoglobin and hemoglobin, 
reacts with oxygen to form superoxide.125 
2.3.2. Reactive Nitrogen Species Production During Exercise/ Interaction with Reactive 
Oxygen Species 
     Acute exercise has been found to result in increases in reactive nitrogen species formation, 
specifically nitric oxide, and to alter nitric oxide synthase activity.104, 68  During physical 
exercise, increases in blood flow and shear stress in the vascular system triggers the release of 
nitric oxide in order to enhance vascular function.92  It has also been proposed that nitric oxide 
may be influenced by repetitive muscle contractions during exercise.103  In addition to the 
influence of reactive oxygen species, nitric oxide may also influence the oxidant-antioxidant 
balance in skeletal muscle.103  It has been speculated that increases in reactive oxygen and 
nitrogen during aerobic exercise contributes to increased oxidative cellular damage.102 
2.4. Determining Reactive Oxygen and Nitrogen production during exercise 
     The direct quantification of free radical production in response to oxidative stress is difficult 
to perform due to  the extremely short half life of the free radical biomolecule.15   The most 
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sensitive direct measure of free radical concentration is electron spin resonance spectroscopy, 
which is performed in conjunction with spin trapping techniques.121  This technique has been 
used to examine free radical concentrations in the blood of exercising humans.  The results of 
these blood analyses demonstrate an increase in the free radical adduct, α-phenyl-tert-
butylnitrone, and consequent free radical damage as assessed by lipid peroxidation.8  However, 
most studies investigating the effects of cycling exercise on oxidative stress have generally used 
secondary measures such as free radical induced lipid and protein oxidation to estimate free 
radical production.10, 89   
     Expired pentane, a possible by-product of lipid peroxidation, was one of the first 
measurements made to associate reactive oxygen and nitrogen damage and cycling exercise.22  
The accumulation of reactive oxygen and nitrogen results in lipid peroxidation and may also 
contribute to cellular protein oxidation.17  An increase in protein oxidation has been observed in 
response to a single day of a cycling stage race that was considered to be of moderate intensity,14 
indicating the presence of oxidative stress in response to a single day of cycling competition.  
The damage sustained by the muscle cell through this lipid and protein oxidation could 
contribute to altered cellular integrity and metabolism, resulting in impaired muscular 
performance.106   
     The oxidation of muscle cells is one of the processes that leads to altered protein function, but 
tyrosine nitration during inflammatory conditions is also linked to altered protein function.27  It is 
suggested that reactions between nitric oxide and reactive oxygen species result in the formation 
of nitrogen oxide intermediates, such as peroxynitrite, which nitrate proteins.123  Tyrosine 
residues found on proteins are susceptible to nitration by peroxynitrite, resulting in alteration of 
the physiological functions of these proteins and ultimately degradation.115  More specifically, 
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peroxynitrite reacts directly with thiols, such as glutathione at its disulfide bonds, and 
hemoproteins at their metal centers and lipid membranes.99, 88  The product of tyrosine nitration, 
nitrotyrosine, can therefore also be used as a marker of oxidative stress3, 123 and provide an 
indication of the potential for oxidation of thiols and hemoproteins.   
     Levels of serum nitrotyrosine have been shown to rise significantly during a four-day super-
marathon.100  This rise in protein nitration indicates the occurrence of oxidative stress to proteins 
in well-trained endurance athletes.  The event was extreme in nature, in that it lasted for four 
consecutive days totaling 328 km, and one might argue that an event this extreme may not relate 
to usual competitions in which most endurance athletes engage.  With that in mind, it is 
necessary to point out that the levels of serum nitrotyrosine increased after the first day from 9 
mmol·L-1 to 17 mmol·L-1, which consisted of 93 km of running, where they remained for the 
duration of the competition.100  So, it is plausible that endurance exercise lasting only one day 
will still increase oxidative stress as indicated by increases in nitrotyrosine100  and markers of 
protein oxidation.14  Ultimately, the accumulation of the oxidative damage is relative to the 
collective success of the antioxidant and muscle repair systems,101 training status,82, 96 and 
intensity of the exercise.49 
2.5. Antioxidants Fluctuations, Cell Damage, and Oxidative Stress 
     The antioxidant defense system is the body’s endogenous defense mechanism that can 
neutralize reactive oxygen and nitrogen species64 and attenuate reactive oxygen and nitrogen 
species induced oxidative damage. Oxidative stress results when the antioxidant system is 
overloaded and can no longer neutralize the concentration of reactive oxygen and nitrogen 
species being produced.64, 13  In a state of oxidative stress, reactive species are not controlled and 
spontaneous reactions of reactive oxygen and nitrogen species with other oxygen, nitrogen, and 
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sulfur species occurs and causes a cascade of free radical formation,33 which exhausts the 
antioxidant defense system and leads to muscle cell96 and red blood cell damage.113, 116, 117  Thus, 
when the antioxidant defense system is inadequate, damage can occur that might result in 
decreased endurance performance due to muscle tissue loss and decreased capacity to transport 
oxygen.   Although not directly indicative of tissue damage, a popular technique for determining 
oxidative stress includes measurement of antioxidant concentration fluctuations because changes 
in the concentration of antioxidants can point to impairment in the antioxidant defense system.94  
The antioxidant defense system consists of enzymatic (endogenous in origin) and non-enzymatic 
(exogenous in origin) antioxidants,98 and it is usually the exogenous antioxidants that are 
susceptible to deficiency.63 
2.5.1. Non-Enzymatic Antioxidants: Ascorbic Acid and α –Tocopherol 
     Some of the non-enzymatic, exogenous antioxidants include ascorbic acid and α –
tocopherol.33  Ascorbic acid is known to scavenge free radicals in the aqueous phases of cells 
and in the circulatory system, as well as to protect cell membranes from oxidative damage.9  It 
has been demonstrated that supplementation with ascorbic acid attenuates the release of creatine 
kinase after muscle-damaging eccentric exercise.13  It is plausible that ascorbic acid decreases 
oxidative stress by scavenging reactive oxygen species or by regenerating the antioxidant form 
of α –tocopherol 9 to result in the decreased muscle damage.   
     Endurance-trained cyclists who were supplemented with ascorbic acid for a period of two 
weeks, and after 2.5 hours of cycling at 60% VO2max demonstrated no reduction in oxidative 
stress, as indicated by markers of lipid peroxidation. This suggests that ascorbic acid 
supplementation alone is ineffective at reducing oxidative stress.19  However, interpretation of 
this data must be taken with caution.  Cycling at 60% VO2max may not be of adequate intensity to 
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invoke oxidative stress and is therefore not ideal for determining beneficial effects of antioxidant 
supplementation on oxidative stress that might be seen in response to competition or high 
intensity training.  This contention may be supported by the fact that the authors were unable to 
report significant differences in levels of oxidative stress in response to the cycling bout during 
the treatment or placebo intervention.19  Without invoking oxidative stress during the exercise, it 
is difficult to determine the effect of supplementing with ascorbic acid on oxidative stress during 
cycling. 
     A similar study design was employed to investigate the effects of coupled ascorbic acid and α 
–tocopherol  supplementation on oxidative stress in response to cycling.20  This protocol 
consisted of consumption of the antioxidants or placebo for four weeks and investigated the 
oxidative stress response to 2.5 hours of cycling at 60% VO2max in recreationally active males.  
The determining measures of oxidative stress were indicators of lipid peroxidation, F2-
isoprostanes and thiobarbituric acid reactive substances.  Results indicate an increase in F2-
isoprostanes after exercise but no difference in the increases between treatment groups.  The 
thiobarbituric acid reactive substances did show an alteration due to the supplementation, which 
resulted in a significant decrease in thiobarbituric acid reactive substances  after the exercise 
versus the placebo group.  The authors conclude that although a decrease in thiobarbituric acid 
reactive substances  was observed as a result of supplementation, there was no conclusive 
evidence between the two measures to suggest that oxidative stress was attenuated as a result of 
the supplementation protocol.20   
     It is likely that the cycling protocol was not of a high enough intensity to induce oxidative 
stress. The intensity used is not comparable to the intensities observed during actual competitive 
cycling.  Cycling intensities encountered during competitions are ≥75% VO2max,31 a higher 
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intensity than what was used in this study.  Therefore it is difficult to conclude that the 
combination of ascorbic acid and α –tocopherol supplementation would not make a difference in 
reducing oxidative stress during a cycling competition. 
     However, data exists that suggests α –tocopherol is an important antioxidant in maintaining 
endurance performance.  It has been demonstrated that rested α –tocopherol deficient animals 
exhibit similar concentrations of free radicals and lipid peroxidation as exercise-exhausted 
animals.18  During exercise, the α –tocopherol deficient animals exhibited a 40% lower 
endurance capacity than non-deficient controls.18  Thus, an increase in lipid peroxidation, as seen 
during oxidative stress conditions, may contribute to decreased endurance capacity. 
     Supplementation with ascorbic acid has also been demonstrated to prevent increases in 
oxidative stress during exercise.  The attenuation of the increase in the ratio of blood oxidized 
glutathione to total glutathione, an indicator of oxidative stress, was reported during muscle-
damaging exercise as indicated by increases in concentrations of creatine kinase.13  Endurance 
exercise at the intensities encountered during competitive cycling are known to significantly 
increase creatine kinase.42  Thus, it appears that antioxidant Vitamins C and E are important in 
endurance capacity by decreasing oxidative stress, leading to attenuation of oxidative tissue 
damage.  
2.5.2. Non-Enzymatic Antioxidant: Glutathione 
     The non-enzymatic antioxidant reduced glutathione is relevant to oxidative stress.87  Reduced 
glutathione is able to protect cells from the toxic effects of reactive oxygen species by 
detoxification of reactive oxygen species and reactive oxygen species products (i.e. peroxides)87 
and  is used by glutathione peroxidase to neutralize hydrogen peroxide, resulting in the formation 
of oxidized glutathione. 87  Reduced glutathione is considered the most important non-enzymatic 
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antioxidant found in erythrocytes.  Blood reduced glutathione concentrations are generally 
between 800-2000 µM,28, 29, 66 and oxidized glutathione concentrations vary depending on free 
radical induced oxidative stress but have been found to be between 2.0-800 µM.28, 29, 66  
Concentrations also vary depending on the subject’s level of training,71 nutritional intake,51, 66 as 
well as in response to different types of exercise intensities34, 49 and durations of exercise.24, 26, 37  
Training increases the basal reduced glutathione concentration in the blood28 thereby providing 
increased protection against oxidative species during exercise.  It has been reported that 
fluctuations in the glutathione antioxidant system are sensitive to exercise intensities, with 
greater intensities resulting in greater decreases in reduced glutathione.34 
     Under conditions of oxidative stress, a consistent determining marker is blood glutathione 
oxidation.112  A decrease in the reduced glutathione/oxidized glutathione ratio and total 
gluthation concentration is routinely shown in the blood of exercising humans,28, 29, 37, 71, 118 while 
oxidized glutathione/total glutathione  increases.13, 108  This indicates an increase in oxidized 
glutathione, while the reduced glutathione is decreased, which occurs as glutathione reacts with 
reactive oxygen and nitrogen and attenuates further increases in reactive oxygen and nitrogen 
species that could result in oxidative stress. 
2.5.3. Glutathione and Cycling 
     Research indicates that cycling at 65% VO2max for 90 minutes over three consecutive days in 
moderately trained subjects can decrease the reduced glutathione/oxidized glutathione ratio 
during the bout of cycling.124   This reduction in reduced glutathione/oxidized glutathione ratio 
appears to rebound back to pre-exercise levels within 15 minutes after cessation of exercise.  
This rapid rebound is due to the recycling nature of the glutathione antioxidant system.  Oxidized 
glutathione reacts with NADPH to reform reduced glutathione.  Measuring the reduced 
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glutathione/oxidized glutathione ratio level chronically over the consecutive days did not result 
in any significant deviations from baseline.  Thus, there appears to be no cumulative effective on 
the reduced glutathione/oxidized glutathione ratio level, making it ideal to examine acute 
exercise induced oxidative stress in trained cyclists.124  Cycling at 65% VO2max can result in 
oxidative stress but does not result in increased oxidative damage, as assessed by RNA damage. 
The authors conclude that although oxidative stress occurs during submaximal prolonged 
endurance cycling, the stress encountered does not have any cumulative effects.124   
     In another study, cycling at 65% VO2max for 90 minutes in moderately trained subjects 
resulted in a 60% decrease in reduced glutathione and a 100% increase in oxidized glutathione 
concentrations when compared to non-exercise levels.37  Although these exercise models did 
induce oxidative stress, they do not model intensities that competitive endurance cyclists usually 
encounter during high intensity training or competition, making it difficult to determine if 
oxidative damage results from oxidative stress during high intensity cycling. 
     Intensities of greater than 75% VO2max are reported for 93 minutes on typical flat stages and 
123 minutes during hilly stages of a competitive professional stage race.31  These intensities and 
time frames are reported from cycling competitions that engage the world’s best cyclists, so it is 
unlikely that researchers will have access to athletes that are able to reproduce these exact 
intensities for a similar period of time.  It seems appropriate to reproduce these intensities 
because oxidative stress is increased with increases in exercise intensities as determined by the 
glutathione antioxidant system.34  Thus, it is important to define at intensities of 75% VO2max or 
greater. 
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2.5.4. Glutathione’s Synergistic Effect 
     Glutathione is considered to be a key antioxidant due to its ability to detoxify reactive oxygen 
species directly and enhance the function of other exogenous antioxidants, such as ascorbic acid 
and α-tocopherol.43, 84  Enhancing the reduced glutathione concentration in cells may increase 
their resistance to oxidative damage.87  Mitochondrial oxidative damage has been associated with 
muscle degeneration in reduced glutathione depleted animals;83 as such, a cellular deficiency of 
reduced glutathione can be associated with oxidative damage.  The administration of ascorbic 
acid and α-tocopherol in a reduced glutathione deficient state results in attenuation of cellular 
damage,114 which demonstrates the cooperative effectiveness of the exogenous antioxidants and 
the importance of reduced glutathione in preventing oxidative damage.  Therefore, one could 
reason that the administration of not one but many exogenous antioxidants would result in 
greater attenuation of oxidative stress-induced damage, possibly through maintenance of the 
glutathione antioxidant system during acute exercise.  During induced overtraining in trained 
triathletes the basal concentration of reduced glutathione was actually increased in response to 
antioxidant supplementation with ascorbic acid, α-tocopherol, and selenium.96  Furthermore, 
reduced glutathione is a very important molecule to the cell in that it prevents oxidative damage 
but also in regulation of redox-sensitive tissue signal transduction.111 
2.6. Reactive Oxygen and Nitrogen Species and Signal Transduction 
     Although most of the research on reactive oxygen and nitrogen species has focused on the 
deleterious effects associated with disease and tissue damage,102 reactive oxygen and nitrogen 
species have also been shown to regulate an increasing number of signal transduction 
pathways.91  During exercise the increase in reactive oxygen and nitrogen species could induce 
adaptive mechanisms involving antioxidant and repair systems.102  Regulatory elements such as 
kinases, phosphatases, and transcription factors appear to be redox-sensitive.  Fluctuating 
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concentrations of reactive oxygen and nitrogen species exert effects on cell signaling pathways 
through these regulatory mechanisms, which can alter gene expression and muscle adaptation.91 
     Oxidative stress-sensitive signal transduction pathways include the nuclear factor (NF) κ B 
and mitogen-activated protein kinases (MAPKs).  MAPKs are involved in cell functions that 
include cellular growth, proliferation, and adaptation.  NF-κ B activation by reactive oxygen and 
nitrogen species signals for enhanced gene expression of important antioxidant enzymes (e.g. 
mitochondrial superoxide dismutase) due to NF-κ B binding sites in these gene promoter regions.  
Furthermore, acute treadmill running (58 ± 7 minutes) in animals results in significant increases 
in the protein levels of extracellular signal-regulated kinases (ERK) 1/ERK2 and p38 MAPK in 
the upstream NF-κ B signaling pathway, providing further support that reactive oxygen and 
nitrogen species are involved in activating MAPK.  This is evident when the administration of 
allopurinol abolishes production of reactive oxygen and nitrogen species, ultimately attenuating 
the phosphorylation of these enzymes and resulting in decreased ERK1/ERK2 and p38 MAPK 
protein levels.65  This demonstrates that reactive oxygen and nitrogen species are important in 
cellular adaptations that signal for enhanced antioxidant defenses and muscle adaptation. 
     Furthermore, NF-κ B activation is also sensitive to intracellular thiol redox status.  Low levels 
of cytosolic oxidized glutathione are associated with diminished activation of NF-κ B.  On the 
contrary, high oxidized glutathione or low reduced glutathione concentrations inhibit the binding 
site of activated NF-κ B to antioxidant gene promoter regions.  Subsequently, either condition is 
limiting appropriate signals that would result in upregulation of antioxidant defenses.  This 
highlights the concept that there seems to be an intermediate, ideal, intracellular concentration of 
oxidized glutathione needed to facilitate effective NF-κ B activation.23, 111  This is important 
when considering the use of antioxidants during exercise and their effects on the glutathione 
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antioxidant system.  It could be reasoned that cellular adaptations will be blunted if treatment 
with antioxidants results in extremely low levels of oxidized glutathione.  But, if too high of a 
concentration of reactive oxygen and nitrogen species results from a cascade of free radicals 
during exercise-induced oxidative stress, copious amounts of reduced glutathione will be 
oxidized to oxidized glutathione, resulting in inhibition of the appropriate cellular signals that are 
necessary to increase the antioxidant defense system.  Therefore, it is ideal to examine the 
glutathione antioxidant system when investigating the effects of antioxidant supplementation. 
     Although it appears an ideal physiological level is necessary for desirable signaling events the 
specific concentrations have not been reported.  Cellular research leading to this hypothesis of an 
ideal concentration is based on the administration of buthionine sulfoximine to deplete reduced 
glutathione and pyrrolidinedithiocarbamate to replenish reduced glutathione.111  The actual 
concentration of reduced glutathione or oxidized glutathione was not measured. 
2.7. Efficacy of antioxidant supplementation 
     The efficacy of antioxidant supplementation is currently in question due to the concept that 
attenuation of reactive oxygen and nitrogen species by antioxidant quenching mechanisms will 
result in diminished cellular adaptations that are seen to be beneficial to oxidant-antioxidant 
homeostasis.65  However, long-term supplementation of six weeks has resulted in improvement 
in cycling time trial performance.81  It is conceptualized that antioxidant supplementation will 
reduce oxidative stress and oxidative stress-associated muscle damage, though research in this 
area provides varying results.69 An underlying reason for discrepancies in the literature could be 
a result of the exogenous antioxidant intake by the subjects independent of the 
supplementation.39  There exists a delicate balance between reactive oxygen and nitrogen species 
eliciting adaptation and reactive oxygen and nitrogen species resulting in accumulation of 
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oxidants.  For individuals who engage in high-intensity aerobic exercise, antioxidant 
supplementation may provide a larger protective margin against the detrimental effects of 
reactive oxygen and nitrogen species.63   
     Cyclists routinely engage in high-intensity aerobic exercise during training and 
competitions.31 Additionally, competitive cyclists must maintain a low body weight by 
decreasing caloric intake to achieve maximal relative power measures.  This is imperative when 
evaluating uphill cycling performance where a gain of 3 kilograms of body weight could 
decrease performance by 1:15 (minutes:seconds) during a 20 kilometer time trial on a 6 % 
grade.61  Complicating the matter further is the fact the cyclists burn a huge number of 
kilocalories, approximately 500 per hour depending on intensity, and without supplementation 
can have inadequate nutritional intake of antioxidants during days of intense competition.107  
Even though some adaptation of the antioxidant systems can occur,102 the adaptations may not be 
adequate to prevent oxidative damage in a nutrient-deficient state.97  Thus a nutritional 
supplement that provides antioxidants and energy does seem to be ideal for some endurance 
athletes.80,63 
2.8. Antioxidant and Energy Substrate Supplementation 
     Using a two day protocol [75% VO2peak for Day 1, 85% VO2peak Day 2] in 15 male cyclists 
(VO2max 52.6 ± 10.3 ml·kg-1·min-1), researchers demonstrated that time to fatigue can be 
increased by 29% for the first ride and by 40% for the subsequent ride with the consumption of a 
carbohydrate + protein drink compared to carbohydrate only.  This finding could possibly be due 
to the higher caloric content of the carbohydrate + protein beverage used in the study.  The 
carbohydrate + protein beverage contained 25% more calories than the carbohydrate beverage, 
4:1 carbohydrate:protein, 7.3% carbohydrate and 1.8% protein. The beverage was consumed 
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every 15 minutes during the cycling bout (1.8 ml·kg-1) and immediately after (10 ml·kg-1).109  
Although the performance data from this study could be due to higher energy content, another 
relevant finding was a decrease in creatine kinase levels.  The concentration of creatine kinase 
was 83% lower when comparing the post-exercise values between carbohydrate + protein and 
carbohydrate (216.3 ± 122.0 versus 1318.1 ± 1935.6 U·L-1).109  Thus, consumption of a beverage 
with carbohydrate + protein during and after cycling seems to attenuate muscle damage resulting 
in improved performance. 
     Using a similar study design, the same group examined the effect of a carbohydrate + protein 
gel versus carbohydrate gel on performance in 8 male and 5 female cyclists (VO2Peak=57.9 ml·kg-
1·min-1).  In this study the cyclists rode 13% longer with the carbohydrate + protein gel (116.6 ± 
28.5 minutes) versus the carbohydrate gel (102.8 ± 25.0 minutes). The supplement design 
maintained a 4:1 carbohydrate:protein ratio.  Again, the supplements were matched for 
carbohydrate concentration and the carbohydrate + protein had a higher caloric content, which 
may have accounted for part of the performance difference seen between treatments.  The gels 
both contained 0.15 g·kg-1 of carbohydrate, and the carbohydrate + protein gel also contained 
0.038 g·kg-1 of protein.  The creatine kinase levels were increased after exercise for both 
treatments, but the increase was only significant for the carbohydrate treatment.110  Thus, the 
carbohydrate + protein gel may have attenuated muscle damage, which lead to improvements in 
performance. 
     These studies demonstrate that the use of a supplement containing both carbohydrate and 
protein can decrease markers of muscle damage.  The addition of extra calories in the form of 
protein seems to prolong exercise to exhaustion, and this performance improvement is enhanced 
over subsequent days.  A longitudinal study comparing the effects of isocaloric carbohydrate and 
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carbohydrate + protein supplements in two groups of cyclists matched for performance could 
provide the answer as to whether there are any benefits of using a carbohydrate + protein 
beverage or gel to decrease creatine kinase levels.  One could reason that a reduction in muscle 
damage between bouts of fatiguing exercise could decrease recovery time leading to a higher 
training volume and intensity.  This increase in training quality could ultimately lead to 
measurable improvements in performance. 
     Recent research109 reports a decrease in muscle damage from the use of a carbohydrate + 
protein beverage versus carbohydrate only, suggesting that this decrease in muscle damage 
should lead to performance maintenance in subsequent rides.  This lead to the examination of the 
effects of two different isocaloric drink supplements, carbohydrate-protein-antioxidants versus 
carbohydrate, on cycle ergometry to fatigue in 14 moderately fit male cyclists (VO2Max = 59.8 ± 
11.9 ml·kg-1·min-1).105  Cyclists underwent two rides to fatigue, one at 70% VO2peak on day 1 and 
another at 80% VO2peak on day 2 (22-24 hours later) to examine the effects of the supplements on 
performance during subsequent fatiguing rides.  This protocol was also chosen to mimic day-to-
day training and dietary practices that are common in competitive cyclists.  Blood samples were 
drawn for determination of plasma lactate dehydrogenase at baseline and 72 h after the first bout 
of fatiguing exercise and for plasma creatine kinase at baseline and 24 hours after the first 
exercise bout.  These sampling points were chosen because the examined measures should 
exhibit peak concentrations at these time points.105  The supplements consisted of a 12 ounce 
beverage to be consumed during the exercise [carbohydrate-protein-antioxidants: 139 kcal, 7.5% 
carbohydrate, 1.8% protein, 200% RDA for Vitamins C and E; carbohydrate: 140 kcal, 12 oz, 
9.3% carbohydrate] and another 12 ounce beverage of higher nutrient density to be consumed 
immediately after the exercise [carbohydrate-protein-antioxidants: 277 kcal, 15% carbohydrate, 
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3.6% protein, 1330% RDA for α –tocopherol , 780% RDA for ascorbic acid; carbohydrate: 277 
kcal, 18.6% carbohydrate]. There was no difference in performance between the carbohydrate 
and carbohydrate-protein-antioxidants according to the total performance time (138.1 ± 39.3 
versus 140.9 ± 43.7 minutes).  However, the concentration of creatine kinase revealed a 
significant attenuation of muscle damage when comparing baseline versus 24 hours with the 
carbohydrate-protein-antioxidants supplement (187.5 ± 119.0 versus 272.9 ± 169.4 U·L-1) when 
compared to the carbohydrate supplement (202.6 ± 120.0 versus 582.0 ± 474.9 U·L-1).  Lactate 
dehydrogenase was significantly elevated at 72 hours after the first bout of exercise in the 
carbohydrate versus carbohydrate-protein-antioxidants (495.1 ± 63.7 U·L-1 versus 450.7 ± 43.1 
U·L-1).105 
     Increased creatine kinase and oxidative stress have been associated with triathletes during 
induced overreaching.  These athletes presented with higher creatine kinase values at rest and in 
response to a duathlon test after four weeks of overreaching.96  Oxidative stress was shown to 
increase in response to the overreaching as indicated by decreases in the reduced 
glutathione/oxidized glutathione ratio, which was reduced further in response to a cycling and 
running duathlon test.96  Thus, it appears that increased levels of muscle damage occur in 
conjunction with oxidative stress.  This study also demonstrates that in times of increased 
training stress, specifically induced overreaching, the antioxidant system may not adequately 
adapt, leaving the body susceptible to oxidative damage.   
     In a similar study of induced overreaching in triathletes, antioxidant supplementation with 
selenium (150 μg·day-1), retinyl acetate (1 mg·day-1), ascorbic acid (120 mg·day-1), α-tocopherol 
(1 mg·day-1) enhanced the glutathione antioxidant systems adaptations.  The level of reduced 
glutathione increased significantly during overreaching in the supplemented group.  Furthermore, 
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creatine kinase was attenuated in the supplemented group in response to the duathlon test.  It is 
important to note that these athletes did present with inadequate antioxidant nutritional intake 
prior to supplemenatation.97  So, it appears that in athletes with deficient exogenous antioxidant 
intake, supplementation can enhance the adaptations of the endogenous glutathione antioxidant 
system during periods of induced overreaching and result in attenuation of muscle damage in 
response to a mock competitive event.  The increases in reduced glutathione levels provide an 
extra level of protection against exercise-induced oxidative injury. 
     There is evidence that consumption of antioxidant energy substrate cocktail increases 
endurance performance.  The cycling protocol engaged trained cyclists in a maximal effort 30 
km time trail.  After supplementation for 6 weeks the test group demonstrated a 3% increase in 
performance.81  This could have been due to a reduction in muscle damage, alterations in the 
endogenous antioxidant systems, or an increase in exogenous antioxidant consumption. 
     For an overview of relevant supplement studies according to ingredients in the planned 
treatment intervention refer to Table 1 in appendix D. 
2.9. Cycling Performance  
     Cycling is a dynamic sport, and currently no one laboratory measure predicts the best 
competition performer out of a group.  Many direct and indirect methods exist to determine 
aerobic endurance performance capacity.11  One measure of aerobic capacity uses a graded 
exercise test to determine VO2max.  This measure provides a good indication of the capacity of 
the cardiovascular system and is sometimes referred to as maximal aerobic power.75  Maximal 
aerobic power is of some importance to cyclists, but many other variables also contribute to 
cycling performance in addition to VO2max, such as skeletal muscle adaptations and alterations in 
fuel metabolism.48  
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     The discussion of performance in cycling should consider aerobic endurance capacity and the 
ability to cycle at a high percentage of VO2max for a prolonged duration.11  But many factors 
contribute to a cyclist’s success; power-to-weight ratio and power production at lactate threshold 
(LT)16 are also important factors.  Furthermore, the cyclist’s economy is relative to the power 
that can be sustained at a given percentage of the VO2max,67 which is related to the cyclist’s LT.   
     Another indicator of performance is the ventilatory threshold (VT) determined by breakpoint 
of ventilatory equivalent of oxygen or carbon dioxide (VE/VO2 or VE/VCO2) and respiratory 
exchange ratio (RER).4  The VT has been identified as being accurate in predicting cycling 40 
kilometer time trial performance.4  Furthermore, LT is correlated with performance but is not 
representative of race pace for cycling time trials.70  During a simulated 20 kilometer time trial, 
cyclists were able to ride at intensities greater than their predicted LT of 2 mmol·L-1 above 
baseline, as determined during a graded max test, for over 30 minutes.70  It must also be 
emphasized that motivational and psychological factors can contribute to a cyclist’s athletic 
performance, and there is currently no test to determine the contribution of these factors to 
performance.  Therefore, there is no scientific method that totally examines the performance of a 
competitive cyclist in the lab.67   
     During competition, cycling requires the athlete to maintain high intensities for prolonged 
durations.31  This fact is best represented by the analysis of an individual time trial where 
competitive cyclists spend an average of 20 minutes at >90% VO2Max.31  Additionally, it has been 
reported that the winner of an  individual time trial during the Tour de France cycled at >90% 
VO2Max for 70 minutes.77  Thus, intensities taken from actual cycling competitions can be 
reproduced in the testing laboratory to simulate realistic racing conditions.  In previous studies, 
cycling during a 30 minute time trial in the laboratory setting resulted in a heart rate that was 
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consistently 90% of max.25  Furthermore, it had been reported that heart rate at the onset of blood 
lactate (OBLA) and power output at a fixed blood lactate level of 4 mmol·L-1 is similar to the 
heart rate achieved during performance of approximately 10-39 minutes in elite cyclists.95 
     The analysis of cross-country mountain bike competitions reveals similar intensities as during 
competitive road cycling time trials.50  The cross-country cyclists spent 31% of the mountain 
bike competitions above OBLA.  The average heart rate during 5 competitive cross-country races 
averaged out to be 90% of HRmax for 147 minutes.50  Thus, cycling at high intensities is well-
documented during both mountain bike competitions and road cycling time trials.     
     The classification of the athletes’ performance level may also be a contributing factor to the 
difficulty in drawing comparisons between studies.60  A non-systematic approach of quantifying 
performances has lead to some confusion among outcome measures during cycling studies.  
Thus, performance classifications such as “elite” have variable meanings between colleagues, 
making comparisons among studies unreliable.  In 2000, a unified classification system was 
proposed by Jeukendrup et al.60 that allows for the universal comparison of cycling research.  
Using this systematic approach for classification of the cyclists’ level of performance will allow 
data to be compared across multiple publications.  Thus, the systematic approach including both 
performance measures and quantification of training and racing history60 allows for better 
classification of a cyclist’s actual performance level.    
2.10. Appropriate protocol for examining nutritional intervention 
     The use of test/re-test protocols during cross-over study designs to measure the effect of 
supplementation and training implementation on performance is widely accepted. 105, 109, 110  
However, just because a test offers some measure of performance (i.e. VO2max or LT) does not 
mean that improvements in test performance will translate to competitive performances, or that 
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the athlete has improved at all.  It could simply be that the athlete has improved performance 
during the test due to increased motivation or due to familiarization with the test protocol during 
previous testing procedures.  Tests must be reliable and validated, and the athlete must be 
familiarized with the test prior to performance data is collected.   
     One of the most reliable methods of determining improvements in cycling performance is to 
first provide the athlete with a preliminary familiarization ride where the subject is preloaded 
with a set time and work rate (i.e. 45 minutes at 70% maximal power output).  The cyclist 
subsequently undergoes a work time trial at simulated race pace, performing as much work as 
possible within a pre-set amount of time (i.e. 15 minutes) normally at intensities of ~90% 
HRmax, which is similar to those encountered during competitive cycling competitions.29, 74, 25, 
95, 50  During the treatment period, the actual testing protocol includes the preload, followed by a 
timed bout reaching the previously determined amount of work that was completed in the final 
15 minutes during the familiarization ride.58  This preload+time trial technique is a reliable 
test/retest protocol, as indicated by a coefficient of variance of 3.49%.58 
     Another consideration is the familiarity of the cyclists to the testing protocol.  Usually the 
more familiar the cyclist becomes with the test, the better his performance will be.58, 73  A control 
used to minimize this problem is the familiarization ride.  The cyclist will complete the testing 
protocol without any treatment intervention (i.e. a preliminary ride).  This ride will act as the 
learning curve so that under the treatment conditions that athlete will have already experienced 
the test.  The cyclist will then repeat the protocol under the treatment or placebo conditions for 
an actual measure of performance.73 
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2.11. Limitations in Current Supplement Research 
     Some limitations of the above research reviewed include variability in the duration of fasting 
prior to the bout of exercise, the control of outside diet and exercise, and time between 
administrations of the treatment or placebo in the crossover designs (washout periods).  
Generally the literature reports recovery/washout periods varying in length of time, from 6-14 
days110, 109, 105 between treatment trials.  This variable length of time can make it difficult when 
analyzing data from different studies.  When comparing dietary and training controls, some 
studies report that athletes had limited food intake for four hours prior to testing sessions, but 
failed to report any control over exercise outside of the study.105  Furthermore, other studies do 
not report any control over the diet or exercise outside of the study,109 yet others report dietary 
control for 24 hours prior to testing and exercise limitations for 48 hours prior to testing.110  
Training and food intake should be documented in the event that a study administers a cross-over 
design and analysis should be performed to determine if there existed any difference prior to the 
testing sessions.  In the event that a difference is found in training or diet prior to the trials the 
subjects data must be eliminate or test re-administered.  An ideal research design should examine 
the effect of supplementation in a manner which is consistent with the typical training practices 
of athletes.  These include hard and light days of training and familiarity with the standardized 
guidelines prior to data collection.  In addition, the diet should be what the athlete regularly 
consumes for the duration of the study with controlled intake 12-24 hours prior to the exercise 
trial.  Furthermore, this method could in turn promote accurate record keeping among the 
athletes in the study by allowing them to train without restrictions, as long as they train similarly 
prior to all testing and experiment protocols.  This method does include some guidelines, such as 
only light exercise 48 hours prior to testing and refraining from exercise 24 hours prior to testing. 
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Another limitation of these studies is the testing protocol.  Although one commonly used method 
to measure alterations in performance is cycling until exhaustion at a pre-determined intensity 
level,110, 109, 105 this method is not appropriate for practical application in athletes.122  Exercise 
time-to-fatigue is a poor measure for the analysis of cycling performance because the athlete 
very rarely engages in this type of activity.  However, fixed distance time trials closely simulate 
training practices and/or racing events.58  Overall, it is difficult to compare data collected on 
supplement studies because the protocols between studies vary for recalling exercise and diet 
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PURPOSE:  To determine if 5 days of antioxidant supplementation coupled with a pre-ride 
antioxidant/energy supplement improves cycling performance or reduces oxidative stress in 
trained cyclists. 
METHODS:  Eight well-trained cyclists participated in a double-blind cross-over placebo-
controlled study.  Maximal oxygen consumption (VO2Max), peak power output (WMax) and total 
work during a 15-minute time trial were determined.  Subjects consumed an antioxidant 
supplement (S) or a placebo (P) for 5 days before each trial and a pre-exercise supplement or 
isocaloric placebo (4 kcal·kg-1) 45 minutes before each trial.  Subjects performed an endurance 
ride of 90 minutes followed immediately by a time trial requiring accumulation of total work 
equal to the initial time trial. 
RESULTS:  The GSH:GSSG ratio remained constant prior to both experimental trials, while  
resting total GSH concentrations exhibited a main effect (p = 0.038) in response to step-one of 
the supplement protocol for basal (S: 1020.2 ± 135.8 µmol·L-1; P: 1000.2 ± 252.9 µmol·L-1) vs. 
pre-endurance (S: 979.2 ± 155.1 µmol·L-1; P: 867.3 ± 231.2 µmol·L-1).  During the endurance 
ride, no differences were observed in average power (S: 224.0 ± 36.5 W; P: 219.1 ± 19.2 W), 
oxygen consumption (S: 2.8 ± 0.4 L·min-1; P: 2.8 ± 0.4 L·min-1), heart rate (S: 148.4 ± 3.5 
beats·min-1; P: 146.3 ± 4.5 beats·min-1), or GSH:GSSG ratio (S: 1.4 ± 0.7; P: 1.4 ± 0.9).  During 
the time trial tests, supplementation did not lead to any differences between average power (S: 
303.6 ± 59.2 W; P: 306.1 ± 47.0 W), oxygen consumption (S: 3.5 ± 0.4 L·min-1; P: 3.3 ± 0.6 
L·min-1), heart rate (S: 171.1 ± 6.5 beats·min-1; P: 170.3 ± 3.5 beats·min-1), or GSH:GSSG ratio 
(S: 1.1 ± 0.6; P: 0.9 ± 0.7). 
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CONCLUSION:  Consuming an antioxidant supplement for 5 days coupled with a pre-exercise 
antioxidant/energy supplement does not result in significant improvements in cycling 
performance.  However, the multiple-step supplementation may attenuate oxidative stress during 
the cycling bout when compared to a placebo, possibly due to the maintenance of glutathione 
levels. 
Key Words:  Bicycling/physiology, Energy Metabolism, Sports/physiology, Physical 
Endurance/physiology, Oxidative Stress, Glutathione/blood 
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INTRODUCTION 
     Competitive endurance athletes routinely engage in high intensity exercise during competition 
(20).  During an individual time trial, competitive cyclists spend an average of 20 minutes at 
>90% maximal oxygen consumption (VO2Max) (20).  The analysis of cross-country mountain 
bike competitions reveals similar intensities as during competitive road cycling time trials.  
Competitive cross-country mountain cyclists averaged 90% of maximal heart rate (HRMax) for 5 
cross-country races that averaged 147 minutes (36).   
     In order to meet this work demand, a constant supply of energy to the working muscles must 
be provided to maintain performance during high intensity aerobic exercise (39, 48).  The 
metabolic processes in the mitochondria result in the formation of free radicals and other reactive 
oxygen species (31), which subsequently leads to the formation of reactive nitrogen species (84).  
Antioxidants quench free radicals and reactive oxygen and nitrogen species, thereby reducing the 
severity of oxidative stress (24).  Oxidative stress occurs as a result of an imbalance between 
reactive oxygen and nitrogen species and the antioxidant defense system (41).   
     The accumulation of reactive oxygen and nitrogen species can occur during high-intensity 
exercise (25) leading to oxidative stress (42), oxidative red blood cell damage (75, 79), and 
oxidative muscle damage (27, 67).  Markers of muscle damage are shown to increase after 
prolonged high-intensity cycling (27, 72, 73), and this oxidative damage may result in a decrease 
in endurance performance due to muscle tissue loss and decreased capacity to transport oxygen.  
The accumulation of oxidative damage is relative to the production of reactive oxygen and 
nitrogen species (41) and the collective success of the antioxidant defense and muscle repair 
systems (65). 
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     Recent studies have examined the effect of various dietary supplements on their ability to 
enhance endurance performance (53), alter fuel metabolism (22, 57), decrease markers of 
oxidative stress (54, 71), and decrease markers of post-exercise muscle damage (27, 65).  These 
dietary supplements include carbohydrate (39, 48), protein (51, 73, 81), arginine (1, 57), 
carnitine (8), aspartate (1), tartrate (8), retinol, ascorbic acid, and α-tocopherol (2, 11, 12, 54, 62, 
75), selenium (65, 77), allopurinol (27), Siberian ginseng (19), and reduced glutathione (71). 
Most of these supplements have required long-term (~ 4 weeks) use to provide the desired 
effects (2, 12, 27, 53), and most have been studied independently of one another (11, 27, 57, 62, 
77). 
     It has been suggested that because most of these supplements work synergistically, they 
should be consumed in combination as an antioxidant energy substrate cocktail, rather than 
independently (74).  Thus, supplementation with antioxidant energy substrate cocktails has also 
been evaluated in regards to providing ergogenic effects (53, 78).  There is evidence that the 
consumption of an antioxidant energy substrate cocktail for 6 weeks increases endurance 
performance (53), but the authors failed to identify any underlying mechanisms.   
     It has recently been proposed that long-term antioxidant supplementation may be detrimental 
to cellular adaptations that lead to improvements in endurance capacity (26, 31).  A number of 
cellular signaling pathways respond to reactive oxygen and nitrogen species, which ultimately 
contributes to improvements in endurance performance (43).  Long-term supplementation may 
prevent desirable adaptations in inducible antioxidants, limiting the adaptive capacity to deal 
with reactive oxygen and nitrogen species (43). 
     Short-term antioxidant supplementation may be an alternative method that avoids the 
problems associated with long-term antioxidant intervention.  These protocols may lead to 
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improvements in performance without interrupting cellular adaptations that occur as a result of 
normal training.  A few studies have investigated the effect of short term (≤14 days) antioxidant 
supplementation on oxidative stress and performance (5, 33, 79).  These supplementation 
protocols varied in timing from 2 hours (5, 79) to 14 days (33) prior to exercise.  A graded 
cycling max test coupled with ascorbic acid supplementation taken 2 hours prior to the high 
intensity aerobic exercise bout was shown to increase plasma ascorbic acid levels and decrease 
oxidative stress at rest and in response to the exercise in healthy untrained subjects (5).  This 
indicates that short-term supplementation may therefore be beneficial in reducing oxidative 
stress by attenuating uncontrolled production of reactive oxygen and nitrogen species that can 
lead to an oxidative stress condition.  An antioxidant energy substrate cocktail may provide 
increased levels of protection beyond that of independently supplementing with only one 
supplement type, but there currently exists no scientific literature evaluating this concept.  Thus, 
more research on the effects of short term antioxidant cocktail supplementation protocols on 
cycling performance in trained athletes is warranted.  Therefore, the purpose of this project was 
to determine if a multiple step antioxidant nutritional supplement protocol which includes a 5 
day antioxidant cocktail loading phase coupled with a pre-event antioxidant/energy beverage 
increased performance, reduced markers of oxidative stress, or enhanced fuel metabolism during 
a high-intensity cycle ergometry exercise test in trained competitive cyclists. 
 
METHODS 
Experimental Design.  The present study was conducted using trained cyclists in a repeated-
measures double-blinded crossover design to investigate the effects of a multiple-step 
antioxidant energy supplement protocol.  Oxygen consumption (VO2), heart rate, whole blood 
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lactate, plasma glucose, and markers of oxidative stress were determined intermittently during 
the experimental trials.  The subjects were tested on four different occasions.  The first testing 
session was used to determine the cyclists’ anthropometrics, body composition, VO2Max, HRMax, 
peak power output (WMax), and ventilatory threshold.  The second session, which took place 5 
days later, was used to determine the maximal amount of work the cyclists could perform during 
a 15 minute time trial.  The third and fourth sessions were the experimental conditions where the 
cyclists were randomly assigned to either treatment or placebo conditions in a crossover design.  
The third testing session took place 7 days after the second and the fourth testing session took 
place 12 days after the third.  Refer to Figure 1 for a summary of the testing timeline.  Authors 
controlled for time of day and pre-ride nutrition and training; subjects reported to the testing 
laboratory and consumed a similar diet and engaged in similar training practices prior to each 
testing session. 
Subjects.  Subjects were cyclists with at least two consecutive years of competitive cycling, no 
current injuries or exercise restrictions, and who had not consumed antioxidant nutritional 
supplements for the last thirty days prior to the initiation of the study.  Eligibility was determined 
using a health history questionnaire and a separate questionnaire specifically designed to obtain 
information on cycling background and supplement use.  Subjects provide informed consent and 
received a description of events for the study.  The West Virginia University Institutional 
Review Board approved (#9999-16954) the study protocol statement including all forms and 
procedures.  A summary of subject characteristics are presented in table 1. 
Preliminary Testing.  Subjects refrained from intense training for 24 hours prior to all testing 
procedures but were allowed to follow their usual exercise and competition patterns.  Preliminary 
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testing began with determination of body composition by air displacement using a BodPod (Life 
Measurement, Inc., Concord, CA).     
     The same lab technician determined the cyclists racing bike measurements and reproduced 
the identical cycling position on all testing bikes for all procedures during the study.  The cyclist 
performed a 10-15 minute warm-up at a self-selected intensity on a fixed-gear CycleOps 300PT 
(CycleOps, Madison, WI) with the incorporation of two 30 second sprints, a modified version 
previously used by Dumke et. al. (14).  Subjects underwent a continuous incremental cycle test 
(25 W/minute step increment every 1 minute, initial load 125 W) to exhaustion to determine 
VO2Max, WMax, and ventilatory threshold on a electronically braked cycle ergometer (LODE-
Excalibur Sport, Electra Med Corp., Flint, MI) equipped with their own pedals (28).  Oxygen 
consumption was measured continuously by directing expired air to a MedGraphics CardioO2 
system (Medical Graphics, St. Paul, MN) (14).  Heart rates were monitored continuously using a 
4-lead exercise ECG (Welch Allen, CardioPerfect, Skaneateles Falls, NY), and Borg rating of 
perceived exertion (RPE) was documented for every stage (7).  Cyclists maintained a cadence 
between 80-110 revolutions per minute (rpm) throughout the test (20).  Tests were terminated at 
volitional exhaustion and the criteria for determination of a maximal exercise test, plateau in 
VO2, 90% of age predicted HRMax, and respiratory exchange ratio (RER) ≥ 1.15, was used to 
determine if the test was maximal (2).  The ventilatory threshold was determined from the 
VO2Max test by standard procedures (4). 
Multiple Step Supplement Protocol.  Subjects were randomized in a double blind fashion to 
treatment or placebo upon entry into the study and later crossed-over to serve as their own 
controls.  During step-one of the supplement protocol, subjects were instructed to consume 4 
capsules·day-1, 2 in the a.m. and 2 in the p.m., of treatment, antioxidant supplement (ProStandard 
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Endurance®, AmeriSciences®, Houston, TX), or placebo for five days prior to the first 
experimental trials.  Capsules were identical in appearance and taste. See table 2 for a list of 
ingredients in the treatment capsules and see table 3 for a list of ingredients in the placebo 
capsule.  In the case of a cyclist forgetting to consume the capsules at any given specified time 
they were instructed to consume the missed capsules with the next regularly schedule dose.  The 
cyclist completed consumption of the capsules on the evening prior to the experimental trials and 
all cyclist were able to consume all 20 capsules over the five day step-one loading phase with no 
reported side effects.  The cyclists returned an empty bag that previously contained the capsules 
with a form containing their signature confirming consumption of the capsules (45).  During this 
five day period subjects completed a training log and dietary recall.  During the crossover trial 
subjects consumed a similar diet and performed a similar training load to the first trial, an 
additional dietary recall and training log were analyzed and used to determine if discrepancies 
existed prior to the next trial. 
     Following a 12 hour overnight fast, subjects consumed the second-step of the multiple step 
supplement protocol, the morning of the experimental test rides.  Upon arrival to the testing 
facility, after body weight and a resting blood draw, subjects consumed 4 kcal/kg of body weight 
of either a treatment, antioxidant/energy (ProStandard PreGame,® AmeriSciences®, Houston, 
TX) beverage or an isocaloric placebo beverage dissolved in 0.281 fl.oz. of water per gram of 
powder.  The beverage was consumed in entirety a minimum of 45 minutes prior to the 
commencement of cycling.  The placebo and treatment beverage were identical in color and 
taste, See table 3 for a list of ingredients in the placebo beverage and table 4 for a list of 
ingredients in the treatment beverage.  All cyclists were able to consume and maintain 
consumption of the beverages with no side effects. 
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     After the cyclists completed the first supplement period they entered into a 7 day wash out 
period (6).  After this wash-out the cyclists crossed-over into the second supplement period. 
Baseline Trial.  At least 72 hours after the maximal test cyclists returned to the lab at 7:00 a.m. 
for a familiarization ride on the stationary CycleOps 300PT equipped with their own pedals and 
saddle.  The PowerTap power meter (CycleOps, Madison, WI) in the rear hub of the CycleOps 
300PT has previously been validated for submaximal endurance test (30).  The cyclist used the 
same warm-up method as previously described during the preliminary testing.  The cyclists 
began the time trial from a standing start and were instructed to complete as much work as 
possible in 15 minutes.  The cyclists had full control of their cadence and resistance during this 
time trial.  The total amount of work was recorded in kilojoules during the time trial.  Heart rate, 
VO2, and RPE were measured during the time trial using the same methods as during the VO2Max 
test. 
Dietary & Training Control.  For 5 days prior to each experimental trial, subjects recorded 
their dietary intake using a provided diet journal to document the food preparation method and 
amount consumed.  Each subject was provided with detailed instructions for measuring the food 
and recording it into their 5-day dietary journal.  The 5-day dietary recall prior to the first testing 
session was then used as a menu for the 5 days prior to the second testing session.  The subjects 
were requested to eat foods as similar as possible to those consumed prior to the first testing 
session.  Another journal was filled out prior to the second testing session and reviewed prior to 
initiation of the second test.  If the diet was not found to be similar the testing session was 
rescheduled or the subject was dropped from the study.  This approach to dietary control was 
modified from a previous version used by Kulik et. al. (47). 
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     Similarly, training was recorded for 5 days prior to the testing session using a training journal.  
Subjects provided as much data as possible in the categories of time, average heart rate, average 
power, type/style of workout, distance, speed, and course.  Subjects were to refrain from intense 
exercise 24 hours prior to each experimental test.  The training journal filled out prior to the first 
testing session was then used as a training plan for the week prior to the second testing session.  
During the week prior to the second testing session another training journal was filled out.  The 
journal was reviewed prior to the second testing session and if not found to be similar to the first, 
the subjects was rescheduled or dropped from the study.   
Experimental Trials.  Cyclists returned to the lab at 7:00 a.m. one week after the time trial for 
the first of two experimental trials on the CycleOps 300PT.  The equipment (i.e. pedals and 
saddle) and settings on the CycleOps were identical to previous settings used by each cyclist 
during the time trial.  The cyclists performed a 90 min endurance ride at a work load that 
represented a heart rate of five beats below their ventilatory threshold.  During the endurance 
ride cyclists’ heart rate was measured continuously and RER, VO2, and RPE were measured for 
5 min continuously in 15 min increments, using a modified version of the method of McAnulty 
et. al. (56).  After the endurance ride, cyclists began a high intensity self-paced time trial from a 
standing start.  During the time trial cyclists completed the same amount of work that was 
achieved during the time trial as quickly as possible.  The cyclist had full control of their cadence 
and resistance during the time trial.  The time to complete the amount of work was recorded.  
During the time trial cyclists’ heart rate, VO2, and RPE were measured using the same methods 
as during the VO2Max test.  After a 7 day wash-out and another 5 day loading phase cyclists 
returned to the lab for their second endurance ride and second time trial in identical conditions to 
which the first endurance ride and time trial were performed.   
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Sample Collection.  All samples were collected from the antecubital vein in the forearm into 
EDTA vacutainer® blood collection tubes (Becton, Dickinson and Company, Franklin Lakes, 
NJ) by trained phlebotomists.  Hematocrit was determined and samples were further aliquoted 
into appropriately labeled microcentrifuge tubes for determination of GSH, GSSG, and lactate 
concentrations.  Remaining whole blood was centrifuged (1000 g) for 15 minutes and plasma 
was aliquoted into appropriately labeled centrifuge tubes for determination of blood glucose and 
nitrotryosine.  All aliquoted samples were immediately frozen at -80°C.  A blood volume of 18 
mL was collected at each sampling point.  Prior to the supplement protocol, a resting baseline 
blood sample was drawn after 15 min of rest.  Another resting sample was drawn after the 5 day 
step-one supplement loading phase prior to the consumption of the second-step in the 
supplement protocol on the morning of the endurance ride in similar conditions to the initial 
resting blood draw.  Exercising samples were drawn immediately after the endurance ride and 
time trial.  After a minimum 7-day wash-out period, another baseline sample was drawn at the 
point of crossing-over to the other treatment and a resting sample prior to the endurance ride, a 
post endurance ride sample, and a post time trial sample were all drawn in similar conditions to 
the first testing session. 
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ANALYTICAL METHODS 
Dietary and Training.  Dietary analyses for total calories, fats, carbohydrates, and proteins were 
performed using Food Processor Plus for Windows version 6.05 (ESHA Research, Salem, OR).  
Food Processor Plus was utilized because it has been shown to have a low percentage (0.03%) of 
missing information (49).  Training analysis between groups was performed by totaling the 
number of training sessions.  The number of training sessions was the only uniform method used 
to document training by all subjects. 
Hematocrit.  Whole blood was immediately collected from EDTA tubes into microcapillary 
tubes and hematocrit was determined according to standard procedures. Hematocrit changes 
were used to estimate plasma volume shift for correcting lactate, glucose, glutathione, and 
nitrotyrosine concentrations (80). 
Blood Lactate.  Whole blood was immediately aliquoted from EDTA tubes into pre-chilled 
lactate preservative microcentrifuge tubes (YSI Life Sciences, Inc., Yellow Springs, OH) and 
used for the determination of lactate concentrations.  Preservative tubes were immediately 
vortexed, frozen, and stored at -80°C until analysis was performed.  Lactate analysis was 
performed in triplicate on a YSI Sport lactate analyzer.  The analyzer was calibrated with known 
concentrations of lactate according to standard procedures and all samples were run in triplicate 
and averaged.   If a value was found to be an outlier it was eliminated and the two remaining 
values were averaged.  The raw data was corrected for plasma volume shifts during the 
experimental trials.  Reliability was considered high as can be seen by the coefficient of variance 
and intraclass correlations, 1.2% and 0.99, respectfully.   
Plasma Glucose.  For measurement of plasma glucose, whole blood was centrifuged at 1000 g 
for 10 min.  Plasma was aliquoted into pre-chilled 1ml microcentrifuge tubes, immediately 
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frozen and stored at -80°C until analysis was performed.  Plasma glucose concentrations were 
determined using standard ELISA (Glucose Assay Kit: GAGO20, Sigma, Saint Louis, MO) 
procedures and all samples were run in triplicate.  The raw data was corrected for plasma volume 
shifts during the experimental trials.  Reliability was considered high as can be seen by the 
coefficient of variance and intraclass correlations, 4.9% and 0.94, respectfully. 
Total-body fuel oxidation. Total-body rates of fat and CHO oxidation (g·min-1) were calculated 
during the cycling experimental test from the rate of CO2 production (VCO2) and VO2 by using 
the nonprotein respiratory exchange ratio values according to the following equations (22): 
Fat oxidation (g·min-1) = [1.695 x VO2 (L·min-1)] – [7.01 x VCO2 (L·min-1)] 
CHO oxidation (g·min-1) = [4.585 x VCO2 (L·min-1)] – [3.226 x VO2 (L·min-1)] 
Blood Glutathione.  Whole blood was used for determination of GSH and GSSG.  Whole blood 
was aliquoted into pre-chilled microcentrifuge tubes, immediately frozen, and stored at -80°C 
until GSH analysis.  To prevent further oxidation from occurring in GSSG whole blood samples, 
10 µl of the scavenger 1-methyl-2-vinylpyridinium trifluoromethanesulfonate (M2VP) was 
placed into pre-chilled microcentrifuge tubes prior to the addition of 100 µl of the whole blood 
sample.  GSSG samples were immediately frozen and stored at -80°C until analysis was 
performed. 
     Analysis of GSH and GSSG was performed in triplicate using an assay kit (GSH/GSSG-412 
assay: Calorimetric determination of reduced and oxidized glutathione, Oxis Research®, 
Portland, OR, USA) according to standard procedures (18).  The raw data was corrected for 
plasma volume shifts during the experimental trials.  Reliability was considered high as can be 
seen by the coefficient of variance and intraclass correlations, 5.0% and 0.99, respectfully. 
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Plasma Nitrotyrosine.    Blood plasma was used for determination of nitrotyrosine 
concentrations.  Whole blood was centrifuged at 1000 g for 10 min, the supernatant, plasma, was 
collected without disruption of the white buffy layer of leukocytes.  The plasma was aliquoted 
into pre-chilled 1ml microcentrifuge tubes, immediately frozen and stored at -80°C until analysis 
was performed. 
     Analysis of nitrotyrosine was performed in triplicate using an assay kit (Hbt Nitrotyrosine 
ELISA kit for calorimetric determination, Cell Sciences®, Canton, MA, USA) according to 
standard procedures.  The raw data was corrected for plasma volume shifts during the 




     Paired comparisons were utilized in the analysis of dietary and training log data collected 
during step 1 of the supplement protocol, which encompassed the 5 day supplement period.  
Additionally, a 2 x 2 (treatment x time) repeated measures analysis of variance (ANOVA) was 
utilized in order to determine the differences between the markers of oxidative stress and anti-
oxidant defenses in response to the 5 day supplement protocol.  Follow-up paired comparisons 
were utilized in conjunction with a Holm’s Bonferroni procedure for controlling type I errors 
when significant F values (p ≤ 0.05) were determined (34).  A 2 x 3 (treatment x time) repeated 
measures ANOVA were performed to determine significant differences between the 2 treatment 
trials for lactate, glucose, and markers of oxidative stress at the pre-endurance ride, immediately 
post endurance ride, and immediately post time trial.  When significant F values were determined 
(p ≤ 0.05), paired comparisons were used in conjunction with a Holm’s Bonferroni method for 
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controlling type I errors (34).  All data are reported as means ± standard deviations.  Statistical 
significance was set at the p ≤ 0.05 level of confidence.  All analyses were performed with SPSS 
14.0 (SPSS, Chicago, IL). 
 
RESULTS 
Nutritional intake between the two tests was not significantly different with calories (S: 3407.0 ± 
1112.2 kcal; P: 3432.4 ± 1115.8 kcal), fats (S: 127.7 ± 47.6 g; P: 130.7 ± 47.6), carbohydrates 
(S: 442.3 ± 171.7 g; P: 437.6 ± 164.5 g), or proteins (S: 126.0 ± 48.1 g; P: 123.8 ± 46.3 g).  The 
number of training sessions between the two tests was not significantly different (S: 5.6 ± 5.1 #; 
P: 5.4 ± 5.1 #). 
Performance.  During the controlled endurance ride portion of the cycling protocol there was no 
significant difference between absolute or relative indicators of performance (Table 5) or RPE 
(S: 12.8 ± 0.9; P: 12.5 ± 0.9).  Economy during the endurance ride significantly increased as the 
duration increased for in-trial comparisons, 30-min vs. 60-min (S: 68.7 ± 15.3 vs. 82.6 ± 16.3 
W·L-1·min-1; p = 0.001, η2 = 0.83; P: 69.5 ± 17.5 vs. 85.1 ± 16.1 W·L-1·min-1; p = 0.003, η2 = 
0.73), and 30-min vs. 90-min (S: 68.7 ± 15.3 vs. 84.2 ± 12.9 W·L-1·min-1; p = 0.001, η2 = 0.83; P: 
69.5 ± 17.5 vs. 86.5 ± 14.3 W·L-1·min-1; p = 0.003, η2 = 0.20) (Figure 4).  During the time trial 
portion of the cycling protocol there were no significant differences between trials in the absolute 
or relative indicators of performance (Table 5), time (Figure 2), or RPE (S: 17.1 ± 1.3; P: 16.7 ± 
1.9).  In relation to relative power some cyclists’ performance increased during treatment while 
other cyclists’ relative power was in favor of the placebo (Figure 3).  Economy during the time 
trial significantly decreased as the duration increased for in-trial comparisons, 5-min vs. 10-min 
(S: 94.9 ± 14.0 vs. 81.5 ± 11.8 W·L-1·min-1; p = 0.001, η2 = 0.81; P: 100.1 ± 15.0 vs. 85.0 ± 11.3 
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W·L-1·min-1; p = 0.001, η2 = 0.83), and 5-min vs. 15-min (S: 94.9 ± 14.0 vs. 83.6 ± 12.6 W·L-
1·min-1; p = 0.002, η2 = 0.75; P: 100.1 ± 15.0 vs. 87.9 ± 9.9 W·L-1·min-1; p = 0.002, η2 = 0.77) 
(Figure 5). 
Lactate.  Lactate concentrations were significantly different for in-trial comparisons 
demonstrating a time effect, pre-endurance ride vs. post endurance ride (S: 0.65 ± 0.11 vs. 1.16 ± 
0.23 mmol·L-1; p ≤ 0.001, η2 = 0.86), post endurance ride vs. post time trial (S: 1.16 ± 0.23 vs. 
4.52 ± 1.71 mmol·L-1; p = 0.001, η2 = 0.82) and (P: 0.83 ± 0.24 vs. 5.42 ± 1.97 mmol·L-1; p ≤ 
0.001, η2 = 0.87), pre-endurance ride vs. post time trial (S: 0.65 ± 0.11 vs. 4.52 ± 1.71 mmol·L-1; 
p ≤ 0.001, η2 = 0.85) and (P: 0.89 ± 0.29 vs. 5.42 ± 1.97 mmol·L-1; p ≤ 0.001, η2 =0 .87) (Figure 
6).  There was no significant difference for in-trial comparison of pre-endurance ride vs. post 
endurance ride (P: 0.89 ± 0.29 vs. 0.83 ± 0.24 mmol·L-1; p = 0.643, η2 = 0.03) (Figure 6). 
Glucose.  Plasma glucose concentration demonstrated a time-by-treatment interaction (p = 0.004, 
η2 = 0.92) when comparing basal (S: 4.76 ± 0.72 mmol·L-1; P: 4.51 ± 0.39 mmol·L-1) vs. pre-
endurance ride (S: 4.07 ± 0.66 mmol·L-1; P: 4.70 ± 0.62 mmol·L-1) vs. post endurance ride (S: 
4.83 ± 0.64 mmol·L-1; P: 3.56 ± 0.67 mmol·L-1) vs. post time trial (S: 4.29 ± 0.64 mmol·L-1; P 
4.78 ± 1.05 mmol·L-1) values. 
Total Body Fuel Oxidation.  CHO oxidation rates displayed a significant time effect for 
endurance ride vs. time trial when analyzed by 2x3 ANOVA (S: 3.11 ± 0.37 vs. 5.25 ± 0.62 
g·min-1; P: 2.96 ± 0.57 vs. 4.90 ± 1.42 g·min-1; p ≤ 0.001, η2 = 0.88).  However, post-hoc 
analyses were not statistically different (S: 3.11 ± 0.37 vs. 5.25 ± 0.62 g·min-1; p = 0.069, η2 = 
0.96; P: 2.96 ± 0.57 vs. 4.90 ± 1.42 g·min-1; p = 0.73, η2 = 0.73).  Fat oxidation rates displayed a 
significant time effect for endurance ride vs. time trial when analyzed by 2x3 ANOVA (S: 0.26 ± 
0.13 vs. -0.20 ± 0.15 g·min-1; P: 0.27 ± 0.20 vs. -0.17 ± 0.31 g·min-1; p ≤ 0.001, η2 = 0.857).  
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However, post-hoc analysis were not statistically different (S: 0.26 ± 0.13 vs. -0.20 ± 0.15 g·min-
1; p = 0.15, η2 = 0.93; P: 0.27 ± 0.20 vs. -0.17 ± 0.31 g·min-1; p = 0.69, η2 = 0.69). 
Glutathione.  Resting total GSH concentrations exhibited a main effect (p = 0.038, η2 = 0.04) in 
response to step-one of the supplement protocol when comparing basal (S: 1020.2 ± 135.8 µmol-
1; P: 1000.2 ± 252.9 µmol-1) to pre-endurance ride (S: 979.2 ± 155.1 µmol-1; P: 867.3 ± 231.2 
µmol-1).  Resting GSSG concentrations were not significantly different (p = 0.076, η2 = 0.38) 
when comparing basal (S: 311.7 ± 71.6 µmol-1; P: 304.1 ± 37.4 µmol-1) to pre-endurance ride 
(S: 292.1 ± 53.8 µmol-1; P: 274.0 ± 73.4 µmol-1).  The GSH:GSSG ratio was not significantly 
different (p = 0.893, η2 = 0.003) when comparing basal (S: 1.4 ± 0.7; P: 1.3 ± 0.8) to pre-
endurance ride (S: 1.4 ± 0.7; P: 1.2 ± 0.6) (Figure 7). 
     Total glutathione concentrations were not significantly different (p = 0.070, η2 = 0.59) in 
response to the cycling protocol when comparing pre-endurance ride (S: 979.2 ± 155.1 µmol-1; 
P: 867.3 ± 231.2 µmol-1) vs. post endurance ride (S: 953.1 ± 112.7 µmol-1; P: 971.1 ± 191.1 
µmol-1) vs. post time trial (S: 886.0 ± 146.8 µmol-1; P: 921.2 ± 185.7 µmol-1).  The 
concentrations of GSSG were not significantly different (p = 0.076, η2 = 0.58) in response to the 
cycling protocol when comparing pre-endurance ride (S: 292.1 ± 53.8 µmol-1; P: 274.0 ± 73.4 
µmol-1) vs. post endurance ride (S: 293.0 ± 61.6 µmol-1; P: 298.8 ± 74.6 µmol-1) vs. post time 
trial (S: 292.3 ± 60.1 µmol-1; P: 330.4 ± 86.2 µmol-1).  The GSH:GSSG approached significance 
(p = 0.057, η2 = 0.62) for a treatment-by-time effect when comparing pre-endurance ride (S: 1.4 
± 0.7; P: 1.2 ± 0.6) vs. post endurance ride (S: 1.4 ± 0.7; P: 1.4 ± 0.9) vs. post time trial (S: 1.1 ± 
0.6, P: 0.9 ± 0.7) (Figure 7). 
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Nitrotyrosine.  Nitrotyrosine concentrations were not significantly different (p = 0.445, η2 = 
0.10) between pre-endurance ride (S: 51.65 ± 72.41 nmol·L-1; P: 47.99 ± 60.36 nmol·L-1) and 
post time trial (S: 75.05 ± 124.00 nmol·L-1; P: 83.96 ± 151.11 nmol·L-1). 
 
DISCUSSION 
     The present study was designed to test the effects of short-term antioxidant supplementation 
on prolonged sub-maximal cycling, high-intensity cycling performance, and biochemical 
markers of oxidative stress while cyclists participated in their typical training and racing 
schedules.  Peak aerobic power values, cycling economy, and racing experience classify the 
cyclists as well-trained (Table 1) (40).  Cyclists of this caliber who regularly engage in high-
intensity exercise are expected to benefit from antioxidant/nutritional supplementation (72).  
However, the cyclists in the present study did not demonstrate any performance gains after short-
term supplementation with a multiple-step antioxidant nutritional cocktail. 
     The main finding of this study was that 5 days of antioxidant supplementation and a pre-
exercise antioxidant/energy supplement approached significance for a treatment-by-time effect 
on the GSH:GSSG ratio (Figure 7).  The supplementation attenuated the decrease in the ratio that 
was observed with the placebo in response to the time trial.  However, the supplement protocol 
did not result in any improvements in cycling performance when compared to the placebo 
(Tables 5, Figures 2, 3, 4, and 5). 
     The performance testing protocol used in the present study has been validated for measuring 
endurance performance enhancement due to diet interventions (38).  The high-intensity portion 
of the protocol consisted of a maximal self-paced time trial in which the cyclists averaged 
approximately 85% VO2Max and 90% HRMax (Table 5).  This intensity is similar to what cyclists 
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would engage in during a road time trial or mountain bike competition (36, 63).  Furthermore, 
the high-intensity nature of the time trial is supported by the lactate data (Figure 5).  Lactate 
concentrations increased significantly during the time trial compared to the endurance ride for 
both treatment and placebo trials, and the cyclists achieved lactate concentrations above 4 
mmol·L-1 during the time trial, which is similar to data collected on other trained cyclists (14).  
Thus, we can conclude that similar race intensities were reproduced in the testing scenario. 
     The cyclists’ economy for both the endurance ride and time trial (Tables 4 and 5) 
demonstrated a time effect for both treatment and placebo trials.  After an initial increase, the 
cyclists’ economy leveled-off during the later portion of the endurance ride.  This initial 
improvement in cycling economy was most likely due to a delay in aerobic enzymatic activity at 
the onset of the cycling, while the decrease that occurred during the time trial was most likely 
due to fatigue that results from cycling at a high-intensity.  Typical ratings of economy for 
trained cyclists are reported to be higher than 72 W·L-1·min-1 (40), and economy values for 
highly-competitive cyclists have been reported at 85 W·L-1·min-1 (50).  Cyclists in the present 
study reached greater than 81 W·L-1·min-1 during later portions of the endurance ride and time 
trial. 
     Other similarities with cycling literature are the blood glucose concentrations and CHO 
oxidation rates of the cyclists.  Blood glucose levels ranged from 3.56-4.78 mmol·L-1 throughout 
the testing protocol.  While this seems quite low, the cyclists arrived at the laboratory in a fasted 
state and ingested only 4 kcal·kg body weight-1 prior to the endurance ride.  These values are 
similar to those reported by Dumke et al. (15), which ranged from 3.5-5.2 mmol·L-1.  Total-body 
rates of CHO oxidation were calculated from the RER and, as expected, increased significantly 
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during the time trial.  The values during the endurance ride are also in line with values reported 
from other sources when measured during an endurance cycling bout (10, 22, 32). 
     One aim of this study was to determine if a multiple-step antioxidant nutritional supplement 
alters markers of oxidative stress.  The non-enzymatic antioxidant reduced glutathione has the 
ability to protect cells from the toxic effects of reactive oxygen species and related products (58).  
It is also used by glutathione peroxidase to neutralize hydrogen peroxide, resulting in the 
formation of oxidized glutathione (58), and it enhances the function of other exogenous 
antioxidants, such as ascorbic acid and α-tocopherol (29, 55).  Blood glutathione oxidation is a 
consistent determining marker of oxidative stress (74), as a decrease in the reduced 
glutathione/oxidized glutathione ratio and total glutathione concentration is routinely shown in 
the blood of exercising humans (17, 18, 23, 46, 77), while the oxidized glutathione/total 
glutathione ratio increases (9, 71).   
     Blood reduced glutathione concentrations are generally between 800-2000 µmol·L-1 (17, 18, 
44), and oxidized glutathione concentrations vary depending on free-radical induced oxidative 
stress but have been found to be between 2.0-800 µmol·L-1 (17, 18, 44).  Higher reduced 
glutathione concentrations are found during rest, and higher oxidized glutathione concentration 
found during exercise.  Concentrations also vary depending on the subject’s level of training (46) 
and nutritional intake (37, 44), as well as in response to different types of exercise durations (13, 
16, 23) and intensities (21, 35), with greater intensities of exercise resulting in greater decreases 
in reduced glutathione (21).  Training increases the basal reduced glutathione concentration in 
the blood (17), thereby providing increased protection against oxidative species during exercise.  
Our data indicate that the use of an all-natural antioxidant for a 5 day loading phase also has the 
potential to maintain basal total GSH levels during a competitive season (p = 0.038).  Since total 
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GSH is a measure of both GSH and GSSG, the finding that there was not a significant difference 
in the concentration of GSSG suggests that GSH levels were increased, which could potentially 
provide an extra level of protection against oxidative stress during exercise. 
     Furthermore, it is suggested that reactions between reactive oxygen species and nitric oxide 
result in the formation of nitrogen oxide intermediates, such as peroxynitrite, which nitrate 
proteins (82).  Tyrosine residues found on proteins are susceptible to nitration by peroxynitrite, 
resulting in alteration of the physiological functions of these proteins and ultimately degradation 
(76).  More specifically, peroxynitrite reacts directly with thiols, such as glutathione, and 
hemoproteins (66, 60).  The product of tyrosine nitration, nitrotyrosine, can therefore also be 
used as a marker of oxidative stress (3, 82) and provide an indication of the potential for 
oxidation of thiols and hemoproteins.  However, our data indicated no significant changes in the 
nitrotyrosine concentrations with exercise. 
    The non-significant changes in the glutathione antioxidant system and nitrotyrosine 
concentrations indicate that a 90-min cycling exercise at a heart rate of five beats below the 
ventilatory threshold, approximately 65% VO2Max, did not appear to induce oxidative stress in 
trained cyclists, although reductions in the GSH:GSSG ratio did occur during the time trial.  The 
findings during the preload portion of the cycling protocol are inconsistent with the observations 
from other studies which have used long-duration cycling exercise as a means to induce 
oxidative stress as indicated by glutathione status (23, 83). 
     A potential reason for the discrepancy in our oxidative stress results could be due to sample 
collection procedures.  While both Gohil et al. (23) and Viguie et al. (83) also reported no change 
in total GSH levels, they reported increases in GSSG and decreases in GSH.  These changes 
could have occurred during sample collection, where it is possible that GSH was rapidly 
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oxidized to form GSSG.  The methods used in our study involved the use of a fast-acting 
scavenger agent M2VP to neutralize any free radicals present at the time of sample collection 
and prevent any further in vitro oxidation.  Therefore, the discrepancy between past and present 
data is most likely due to the presence of the scavenger in the collection procedure.  The 
concentrations found in our study are in line with those reported by others who have also used 
M2VP (18, 17).   
     In addition, data published after the completion of this study suggests that the best time point 
for sampling blood alterations in the glutathione antioxidant system is 2 hours after the cessation 
of exercise (59), indicating that our immediately post-exercise sampling point may have 
potentially been too early to examine the greatest alterations in the glutathione system.  
However, the study was performed on untrained subjects using an exhaustive treadmill protocol, 
while our study examined trained cyclists.  In addition, another study demonstrated that 
alterations in the glutathione antioxidant system appear to be diminished 30 minutes after the 
cessation of exercise in trained cyclists and runners (23).  Therefore, the immediate post exercise 
time point appears to be appropriate with trained athletes such as those in the present study. 
     To our knowledge, this was the first attempt to use nitrotyrosine as an indicator of oxidative 
stress in response to cycling.  Other studies have successfully used similar cycling protocols to 
induce oxidative stress on other indices such as protein carbonyls and plasma 8-OHdg levels 
(61).  Nitrotyrosine levels have been shown to increase significantly in response to long-duration 
running during a consecutive four-day super-marathon totaling 328 km (67).  This rise in protein 
nitration indicates the occurrence of oxidative stress to proteins in well-trained endurance 
athletes.  While one might argue that an event this extreme may not relate to usual competitions 
in which most endurance athletes engage, the levels of serum nitrotyrosine increased after the 
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first day, which consisted of 93 km of running, and remained at that level for the duration of the 
competition (67).  In the present study, the nitrotyrosine levels increased in response to cycling, 
but the subject pool presented with a large individual variation in the levels of resting and 
exercising nitrotyrosine, which may have masked any significant alterations that may have been 
present.  This individual difference is most likely due to the principle that the accumulation of 
oxidative damage is relative to the collective success of the antioxidant and muscle repair 
systems (68), training status (54, 64), and intensity of the exercise (35). 
     This study was designed to provide insight into whether or not short-term antioxidant 
supplementation is capable of increasing performance by decreasing oxidative stress in trained 
cyclists in response to a high-intensity cycling test during a competitive cycling season.  To 
directly answer this question, a series of events must occur.  First, the exercise protocol must 
disturb the balance of antioxidants/oxidants to establish a state of oxidative stress in the system.  
Second, the biological markers used to asses the stress must be sensitive enough to detect any 
alterations.  Third, the subjects must present with increased performance under a state of reduced 
stress while consuming the treatment.  These series of events would lead to a positive correlation 
that could suggest that short-term antioxidant supplementation may lead to increases in cycling 
performance.  Without the occurrence of all of these events, it is difficult to determine if there is 
any benefit to consuming an antioxidant supplement for a short loading phase prior to highly-
aerobic competitions such as competitive cycling. 
     Perhaps a more demanding protocol such as 3 consecutive days of high-intensity cycling that 
closely resembles a stage race could increase oxidative stress levels and subsequently result in 
greater levels of fatigue.  Such a protocol has been used to examine the effects of a beverage 
containing carbohydrate, protein, and antioxidants over 2 days of consecutive cycling, but while 
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levels of creatine kinase were decreased, the authors were unable to show an increase in 
performance and failed to examine any indicators of oxidative stress (70).  Furthermore, during 
the Tour de France, the administration of allopurinol, an inhibitor of the free radical-generating 
enzyme xanthine oxidase, did attenuate increases in the marker of lipid peroxidation 
malondialdehyde but did not result in any increases in performance (27).  These data indicate 
that a multiple-day protocol induces muscle damage and oxidative damage, respectively; 
therefore, a multiple day protocol could be useful in determining the effects of short-term 
antioxidant supplementation. 
     In summary, although this study does not indicate that a short-term multiple-step antioxidant 
nutritional supplement protocol results in improved cycling performance, according to the data 
collected on the glutathione antioxidant system it does provide some level of protection against 
oxidative stress.  Even though some adaptation of the antioxidant systems can occur (69), the 
adaptations may not be adequate to prevent oxidative damage in some athletes (65) or to improve 
performance.  A nutritional supplement that provides antioxidants and energy could be ideal for 
some endurance athletes (52, 41), and research should continue to evaluate its effects on 
oxidative stress and performance using novel antioxidant supplements. 
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Table 1. Subject Characteristics 
Variable Mean ± SD Range 
Age (years) 28.9 ± 7.2  (22-44) 
Body Mass (kg) 77.5 ± 7.0 (69.5-88.2) 
Height (cm) 178.1 ± 6.3 (171.8-191.0) 
Racing Experience (years) 9.9 ± 4.9 (3-20) 
Max heart rate (b·min-1) 186.5 ± 7.4 (174-198) 
Body fat (%) 16.4 ± 7.4 (3.3-24.7) 
VO2max (ml·kg-1·min-1) 55.0 ± 5.5 (49.0-65.3) 
VO2max (L·min-1) 4.2 ± 0.3 (3.9-4.7) 
Max power output (W) 400.7 ± 30.7 (350.0-443.8) 
Max power output (W·kg-1) 5.2 ± 0.7 (4.3-6.2) 
Data are presented as mean ± SD; range is in parentheses; N=8.  Max = 
maximum. 
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Table 2. Step-One Treatment Ingredients 
Serving Size: 4 Vegetarian Capsules 
 Amount per 
Serving % Daily Value 
Vitamin C (as ascorbic acid) 100 mg 167% 
Thiamine (vitamin B1) (as thiamine mononitrate) 25 mg 1667% 
Riboflavin (vitamin B2) 25 mg 1471% 
Niacin (as inositol hexanicotinate) 75 mg 375% 
Vitamin B6 (as pyridoxine hydrochloride) 25 mg 1250% 
Folate (as folic acid) 100 mcg 25% 
Vitamin B12 (as cyanocobalamin) 200 mcg 3333% 
Biotin 20 mcg 7% 
Pantothenic Acid (as d-calcium pentothenate) 25 mg 250% 
Calcium (from mineralized seaweed) 100 mg 10% 
Iron (as ferrous bisglycinate) 9 mg 50% 
Zinc (as zinc monomethionine) 10 mg 67% 
Selenium (as selenomethionine) 70 mcg 100% 
Chromium (as chromium picolinate) 120 mcg 100% 
Endurance Proprietary Blend  
Bromelain, Hawthorne Extract (berry), Mullein (leaf), 
Quercetin, Eleuthero Extract (root), American Ginseng 
Extract (root), Cordyceps Extract (mushroom), Devil’s 
Claw Extract (root), Milk Thistle Extract (seed), Nettle 
Extract (root), Turmeric Extract (root), Prickly Ash (bark), 
Cayenne Extract (fruit), Choline (as choline bitartrate), 
Astragalus Extract (root), Panax Ginseng Extract (root), 
PABA (as para-aminobenzoic acid), Bioperine® Pepper 
Extract (fruit), Astaxanthin, Vanadium (as BGOV bis-
glycinato-oxo-vanadium) 
1,107 mg * 
* % Daily Value not established 
OTHER INGREDIENTS:  
Cellulose, Maltodextrin, Silicon Dioxide, Magnesium Stearate 
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Table 3. Step-One and Step-Two Placebo Ingredients 
Product (serving size) Capsules Beverage (24.5 g) 
Calories --- 100 
Total Carbohydrate (g) --- 25 
Listed Ingredients * ** 
* microcrystalline cellulose, manntitol, FDC yellow #5 lake, FDC yellow #6 lake, FDC 
blue #2 lake, magnesium stearate, and silicon dioxide 




Table 4. Step-Two Treatment Ingredients 
Serving Size: 1 packet (24.5 g) 
 Amount 
per Serving 
% Daily Value 
Calories 





     Cholesterol 
0.5 g 




     Dietary Fiber 







Protein 9 g  
Sodium 80 mg 3% 
PreGame Proprietary Blend: 21.2 g * 
* % Daily Value not established 
† Percent Daily Values are based on a 2,000 calorie diet.
Other Ingredients: 
Non Fat Dry Milk, Natural Flavors, Stevia Leaf Extract 
 
Table 5. Performance Data 
Variable Treatment ER Placebo ER t-test Treatment TT Placebo TT t-test 
 Mean ± SD Mean ± SD p η2 Mean ± SD Mean ± SD P η2 
Relative Performance       
Average VO2 36.5 ± 3.2 35.7 ± 4.5 0.35 0.12 45.3 ± 3.5 42.6 ± 6.0 0.19 0.01 
Average PWR 2.8 ± 0.4 2.8 ± 0.4 0.68 0.03 3.9 ± 0.8 4.0 ± 0.6 0.84 0.01 
% VO2max 66.7 ± 7.9 65.4 ± 9.2 0.34 0.12 82.6 ± 5.8 78.1 ± 12.8 0.17 0.23 
        
Absolute Performance       
Average VO2 2.8 ± 0.4 2.8 ± 0.4 0.39 0.11 3.5  ± 0.4 3.3 ± 0.6 0.21 0.01 
Average HR 148.4 ±  3.5 146.3 ± 4.5 0.20 0.08 171.1 ± 6.5 170.3 ± 3.5 0.79 0.01 
Average PWR 224.0 ± 36.5 219.1 ± 19.2 0.58 0.05 303.6 ± 59.2 306.1 ± 47.0 0.84 0.01 
% VO2max 66.9 ± 7.7 65.8 ± 9.7 0.46 0.11 83.3 ± 5.7 78.8 ± 13.2 0.21 0.21 
Time (s) 923.0 ± 118.5 901.5 ± 89.7 0.68 0.03 
Note:  Data are presented as mean ± standard deviation (SD); N=8; Significance was set at p ≤ 0.05; η2 = effect size, ER = 
endurance ride, TT = time trial, Relative performance is expressed per kg, VO2 = oxygen consumption (ml·min-1) or 
absolute (L·min-1), PWR = relative power output (W), % VO2Max = avg percentage VO2Max (ml·min-1) or (L·min-1), and t-





Figure 1. Outline of the experimental approach for the study.  RB1 = resting basal blood sample 
one, RB2 = resting basal blood sample two, RS1 = resting pre-endurance ride blood sample one, 
RS2 = resting pre-endurance ride blood sample two, ER1 = post endurance ride blood sample 
one, ER2 = post endurance ride blood sample two, TT1 = post time trial blood sample one, TT2 
= post time trial blood sample two. 
Figure 2. Cluster plot graph representing the time to finish the time trial portion of the cycle 
ergometry test. 
Figure 3. Cluster plot graph representing the maximal and average relative power during the 
time trial test. 
Figure 4. Line graph of the economy at the 30, 60, and 90 minute time points during the 
endurance ride with standard deviation bars. 
Figure 5. Line graph of the economy at the 5, 10, and 15 minute time points during the time trial 
with standard deviation bars. 
Figure 6. Line graph of the lactate concentration at the pre-endurance ride, post endurance ride, 
and post time trial time points during the cycle ergometry test with standard deviation bars. 
Figure 7. Bar graph of the ratio of GSH:GSSG at the specified time points throughout the study 
















































































































































































Study Treatment Model/Subjects Protocol Results 
Abel, 20051 High dose (H) and low dose (L) of 
arginine (H: 5.7 g·day-1 vs. L: 2.8 
g·day-1) and aspartate (H: 8.7 
g·day-1 vs. L: 2.2 g·day-1) 
30 male trained 
cyclists/triathletes 
4 wks of training with 
H (n=10), L (n=10), 
or placebo (n=10) 
↔ in performance or lactate 
concentration in response to 
cycling (VO2Max test) 
Aguilo, 20072 α –tocopherol  (500 mg·day-1),  β-
carotene (30 mg·day-1), and 
ascorbic acid (1000 mg·day-1) all 
taken twice daily 




3 mo of training with 
α-tocopherol and β-
carotene and 15 days 
with ascorbic acid 
(crossover design) 
↑  % VO2Max at 4mM [lactate] 
significantly higher than 
training alone in response to 
cycling (VO2Max test) 
Broad, 200514 carnitine and tartrate 
(~3.0 mg·day-1) 
15 trained male 
endurance athletes 
4 wks of treatment or 
placebo (crossover 
design) 
↔substrate oxidation or 
cycling performance (90 min 
preload + time trial) 
Davison, 200622 ascorbic acid (1000 mg·day-1) 9 male trained 
endurance athletes 
2 wks of treatment or 
placebo 
(crossover design) 
↓ cortisol, neutrophilia, and 
leukocytosis in response to 
cycling (2.5 at 60% VO2Max) 
 
Davison, 200723 ascorbic acid (1000 mg·day-1) and 
α-tocopherol (400 IU·day-1) 
20 male recreational 
athletes 
4 wks of 
treatment(N=10) or 
placebo(N=10) 
↓ cortisol in response to 
cycling (2.5 at 60% VO2Max) 
Eschbach, 
200034 
Siberian ginseng (1,200 mg·day-1 
standardized extract of ciwujia) α 
–tocopherol  (60 IU·day-1) 
9 male club level 
cyclists 
7 d of treatment or 
placebo (crossover 
design) 
↔ in performance or 
substrate utilization in 
response to cycling (preload 
+ time trial) 
Gomez-Cabrera, 
200346 
Allopurinol (300 mg·day-1) 9 male world-class 
cyclists 
3 wks of treatment 
(N=4) or placebo 
(N=5) 
↓ lipid peroxidation, ↓ muscle 
damage, and ↔ performance 
in response to cycling (during 




selenium (150 μg·day-1), vitamin 
A (2000 IU·day-1), ascorbic acid 
(120 mg·day-1), α-tocopherol (15 
IU·day-1) 
 
16 male professional 
long-distance 
triathletes 
2 wks of taper training 
with treatment (N=7) 
or placebo (N=9) 
attenuation of ↓ in reduced 
glutathione/oxidized 
glutathione ratio and no 
effect on muscle damage in 
response to duathlon (running 
and cycling test) 
McConell, 
200699 
Arginine infusion (30 g at 
0.5g/min) during final 60 min of 
cycling  
9 male endurance 
trained athletes 
Cycling test with 
treatment on placebo 
(crossover design) 
↑ skeletal muscle glucose 
clearance with ↔ on 
performance in response to 
cycling test (preload + time 
trial) 
MacRae, 200693 free radical scavenger cocktail 
(FRS-Q)* or free radical 
scavenger cocktail with quercetin 
(FRS)** (600 ml·day-1) 
11 male elite cyclists 6 wks of treatment 
with FRS or FRS-Q 
(crossover design) 
FRS ↑ performance during a 
cycling test (30 km time trial) 
Nieman, 2004108 α –tocopherol  (800 IU·day-1) 38 world class 
triathletes 
2 mo of treatment 
(N=19) or placebo 
(N=17) 
↑ lipid peroxidation and 





selenium (150 μg·day-1), retinyl 
acetate (1 mg·day-1), ascorbic acid 
(120 mg·day-1), α-tocopherol  
(1 mg·day-1) 
17 male well-trained 
triathletes 
4 wk of normal 
training and 4 wk 
induced over-training 
with treatment (n=7) 
or placebo (n=10) 
↑ in basal reduced glutathione 
level and basal glutathione 
peroxidase activity; 
attenuated creatine kinase ↑, 
and ↑ glutathione peroxidase 
activity in response to a 
duathlon (running and 
cycling test) 
Sastre, 1992123 reduced glutathione (1 g·day-1) 
and ascorbic acid  
(2 g·day-1) 
5 male national-level 
athletes 
treatment for 7 days 
(crossover design) 
attenuation of ↑ in oxidized 
glutathione/reduced 
glutathione ratio in response 
to running (VO2Max test) 
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Senturk, 2005128 retinal (50 mg·day-1), ascorbic acid 
(1,000 mg·day-1), and α-
tocopherol (800 mg·day-1) once 
daily 
9 male trained 
students 
2 mo of treatment attenuation of ↑ in red blood 
cell lipid peroxidation in 
response to cycling (VO2Max 
test) 
Tessier, 1995133 selenium (180 µg) 24 male students 10 weeks of 
endurance training 
with treatment (n=12) 
or placebo (n=12) 
↑ basal plasma glutathione 
peroxidase level, ↔ on 
physical performance 





28 days of treatment 
or placebo 
↑ basal plasma glutathione 
peroxidase level and a ↓ in 
basal plasma lipid 
peroxidation; enhanced 
lactate metabolism in 
response to cycling (multiple 
sprint test) 
*Complete list of ingredients in the FRS-Q cocktail (per 300 ml serving): green tea extract (300 mg), ascorbic acid (150 mg), α-
tocopherol (50 mg), caffeine (45 mg), niacin (25 mg), taurine (9 mg), vitamin B-6 (2.5 mg), vitamin B-2 (2.1 mg), vitamin B-1 (1.9 
mg), vitamin B-12 (0.008 mg), and glucose (60 kJ). 
**Complete list of ingredients in FRS cocktail (per 300 ml serving): quercetin (300 mg) plus the ingredients in the FRS-Q cocktail. 
†Complete list of ingredients in the protein hydrosylate (per sachet): protein (8.3 g), carbohydrate (2.0 g), lipids (0.8 g), sodium (141 
mg), potassium (26 mg), calcium (38 mg), magnesium (189 mg), iron (14 mg), zinc (15 mg), copper (2 mg), manganese (3.5 mg), 
chromium (25 μg), selenium (75 μg), ascorbic acid (120 mg), α-tocopherol (10 mg), niacin (18 mg), vitamin B12 (1 μg), folic acid 
(0.2 mg), thiamin (1.4 mg), riboflavin (1.6 mg), vitamin B6 (2 mg), biotin (0.15 mg), vitamin A (2664 IU), isoleucine (0.55 g), leucine 
(1.07 g), lysine (0.80 g), methionine (0.25 g), cystein (0.33 g), phenylalanine (0.36 g), tyrosine (0.35 g), alanine (0.43 g), threonine 
(0.47 g), tryptophan (0.19 g), histidine (0.16 g), arginine (0.22 g), aspartic acid (0.99 g), serine (0.36 g), praline (0.45 g), glycine (0.40 
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F.1. Biometrics Data Table 
Biometrics 
Subject # Age 
(years) Height (cm) Body Mass (kg) Body Fat (%) 
111 44 176.5 73.58 12.86 
112 22 171.8 77.81 24.65 
114 31 180.5 71.43 19.10 
115 22 173.0 85.90 24.70 
116 25 182.0 69.51   3.30 
117 26 191.0 81.70 12.90 
118 29 176.0 72.14 12.42 
119 32 174.0 88.17 21.42 
Mean 29 178.1 77.53 16.42 
Standard Deviation  7.18 6.3  7.04  7.38 
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F.2. VO2max Testing Data Table 
VO2max 








Max Heart Rate 
(beats·min-1) 
111 55.3 3.889 6.03 443.75 189 
112 50.0 3.879 4.94 384.58 189 
114 54.5 3.858 4.90 350.00 185 
115 52.5 4.714 4.51 387.50 198 
116 65.3 4.474 6.17 429.17 192 
117 53.0 4.352 5.33 435.42 185 
118 60.7 4.321 5.54 400.00 180 
119 49.0 4.350 4.25 375.00 174 
Mean 55.0 4.230 5.21 400.68 187 
Standard Deviation 5.5 0.320 0.69 32.80 7.35 
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F.3. Performance Data Tables 
Table F.3.1. HR Data 
HR 
(beats·min-1) Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 145.78 147.09 176.86 169.79 
112 148.92 148.10 173.02 174.86 
114 145.32 146.78 167.32 170.92 
115 140.26 151.59 167.65 184.79 
116 148.52 147.19 172.03 163.00 
117 148.92 152.86 168.34 170.50 
118 152.98 151.32 170.33 167.95 
119 139.68 142.15 166.70 166.86 
Mean 146.30 148.38 170.28 171.08 




VO2    
(L·min-1) 
Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 2.92 2.79 3.65 3.35 
112 2.59 2.69 3.10 3.35 
114 2.70 2.50 2.45 2.82 
115 2.91 3.17 3.94 3.89 
116 1.96 2.20 2.44 3.42 
117 3.02 3.22 3.51 3.87 
118 3.12 3.03 3.68 3.64 
119 2.92 3.00 3.88 3.85 
Mean 2.77 2.83 3.33 3.52 
SD 0.37 0.35 0.60 0.37 
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Table F.3.2 Absolute VO2 Data 
Table F.3.3. Relative VO2 Data 
Relative VO2 
(ml·kg-1·min-1) Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 39.42 38.15 49.27 45.93 
112 33.61 34.73 40.16 43.24 
114 37.49 35.20 34.10 39.71 
115 33.66 36.93 45.67 45.37 
116 28.26 31.44 35.30 48.93 
117 36.87 39.11 42.86 47.05 
118 42.87 41.76 50.82 50.23 
119 33.50 34.30 42.54 42.06 
Mean 35.71 36.45 42.59 45.32 
SD 4.45 3.22 6.01 3.52 
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Table F.3.4. Absolute Power Data 
Absolute 
Power (W) Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 240 236 345 313 
112 212 209 277 293 
114 197 164 222 166 
115 206 219 328 329 
116 214 237 267 326 
117 242 290 361 363 
118 242 238 337 331 
119 200 199 312 308 
Mean 219.13 224.00 306.13 303.63 
SD 19.22 36.53 46.97 59.26 
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Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 3.26 3.21 4.69 4.25 
112 2.72 2.69 3.56 3.77 
114 2.76 2.30 3.12 2.32 
115 2.40 2.55 3.82 3.83 
116 3.08 3.41 3.84 4.69 
117 2.96 2.80 4.42 4.44 
118 3.35 3.30 4.67 4.59 
119 2.27 2.26 3.54 3.49 
Mean 2.80 2.80 4.00 3.90 
SD 0.40 0.40 0.60 0.80 
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Table F.3.6. RPE 
RPE Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 13.34 14.20 19.35 20.00 
112 12.30 12.89 17.99 16.08 
114 12.41 11.28 12.95 16.72 
115 11.12 12.17 16.87 17.29 
116 11.19 12.98 16.66 15.85 
117 13.03 12.63 17.78 17.48 
118 13.50 12.81 16.58 16.03 
119 12.83 13.43 15.49 17.00 
Mean 12.47 12.80 16.71 17.06 








Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 1.00 0.99 1.12 1.06 
112 0.97 0.96 1.03 1.05 
114 0.93 0.98 0.94 1.02 
115 0.90 0.93 1.04 1.03 
116 0.92 0.95 1.00 1.01 
117 0.90 0.92 1.00 1.02 
118 0.91 0.92 0.98 0.98 
119 0.92 0.94 1.05 1.05 
Mean 0.93 0.95 1.02 1.03 
SD 0.04 0.03 0.05 0.03 
 
Table F.3.8. Time Trial Time 
Time (s) Time Trial 
Subject # Placebo Treatment 
111 803 888 
112 900 852 
114 897 1208 
115 912 908 
116 1102 902 
117 854 852 
118 906 922 
119 838 852 
Mean 901.50 923.00 
SD 89.72 118.47 
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(W·L-1·min-1) Endurance Ride 
 30-min 60-min 90-min 
Subject # Placebo Treatment Placebo Treatment Placebo Treatment
111 78.91 79.73 87.32 93.13 87.96 89.80 
112 74.73 68.32 85.57 80.73 87.17 83.75 
114 75.24 62.41 71.87 67.75 73.48 70.27 
115 50.54 62.93 73.11 73.05 73.87 73.46 
116 104.06 99.10 122.13 117.85 117.75 111.36 
117 56.28 51.02 83.18 77.73 88.14 81.82 
118 59.15 71.95 81.83 80.17 87.86 87.60 
119 57.09 54.39 75.39 70.30 75.94 75.57 
Mean 69.50 68.73 85.05 82.59 86.52 84.20 
SD 17.48 15.34 16.05 16.25 14.26 12.93 
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Table F.3.10. Time Trial Economy 
TT Economy 
(W·L-1·min-1) Time Trial 
 5-min 10-min 15-min 
Subject # Placebo Treatment Placebo Treatment Placebo Treatment
111 98.09 99.76 93.26 93.45 91.01 94.06 
112 99.65 94.04 81.77 82.10 85.68 83.31 
114 74.41 67.87 69.09 54.80 72.93 54.67 
115 91.64 88.48 74.28 80.67 84.91 85.13 
116 122.18 117.49 102.83 88.31 102.98 91.65 
117 118.28 100.08 92.96 88.58 98.01 86.90 
118 99.18 99.34 88.11 84.86 90.06 92.08 
119 97.37 91.75 77.59 79.17 77.61 80.93 
Mean 100.10 94.85 84.99 81.49 87.90 83.59 
SD 14.94 13.95 11.29 11.77 9.91 12.56 
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F.4. Lactate Data Table 
Lactate 
(mmol·L-1)  
 Pre-ER Post-ER Post-TT 
Subject # Placebo Treatment Placebo Treatment Placebo Treatment
111 1.56 0.76 0.83 1.28 6.75 3.44 
112 0.76 0.75 0.57 0.85 2.43 3.35 
114 0.79 0.65 0.96 1.20 3.37 2.64 
115 0.89 0.67 0.62 0.97 6.62 6.91 
116 0.85 0.60 0.80 1.20 4.07 3.01 
117 0.80 0.50 0.78 1.05 6.50 5.02 
118 0.54 0.49 0.72 1.10 5.45 4.76 
119 0.90 0.78 1.33 1.63 8.20 6.99 
Mean 0.89 0.65 0.83 1.16 5.42 4.52 
SD 0.29 0.11 0.24 0.23 1.97 1.71 
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F.5. Glucose Data Table 
Glucose (mmol·L-1) 
 Basal Pre-ER Post-ER Post-TT 
Subject 
# Placebo Treatment Placebo Treatment Placebo Treatment Placebo Treatment 
111 4.21 4.92 4.47 3.19 5.13 5.30 4.81 4.29 
112 3.97 4.10 5.32 4.35 3.03 5.58 3.71 4.08 
114 5.19 4.35 5.19 5.44 3.20 4.94 3.71 4.42 
115 4.62 6.28 4.78 3.53 3.09 4.89 4.67 5.06 
116 4.81 4.01 5.47 3.95 3.55 3.57 5.19 3.90 
117 4.21 5.00 4.30 4.10 3.61 5.33 4.85 4.21 
118 4.43 4.63 4.44 3.88 3.36 4.51 4.26 3.19 
119 4.61 4.84 3.62 4.14 3.52 4.52 7.00 5.21 
Mean 4.51 4.76 4.70 4.07 3.56 4.83 4.78 4.29 
SD 0.39 0.72 0.62 0.66 0.67 0.64 1.05 0.64 
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F.6. Total Body Fuel Oxidation Tables 




Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 4.00 3.72 6.97 5.56 
112 3.22 3.14 4.66 5.31 
114 3.20 2.82 2.69 4.15 
115 2.65 3.30 6.18 5.90 
116 1.98 2.47 3.38 4.84 
117 2.79 3.22 4.84 5.70 
118 2.91 3.01 4.64 4.74 
119 2.93 3.23 5.82 5.81 
Mean 2.96 3.11 4.90 5.25 
SD 0.57 0.37 1.42 0.62 
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Table F.6.2 Fat Oxidation 
Fat Oxidation 
(g·min-1) Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 -0.03 0.01 -0.76 -0.39 
112 0.10 0.18 -0.19 -0.30 
114 0.06 0.30 0.22 -0.14 
115 0.46 0.35 -0.33 -0.25 
116 0.24 0.18 -0.04 -0.09 
117 0.47 0.41 -0.04 -0.18 
118 0.47 0.39 0.09 0.08 
119 0.37 0.29 -0.31 -0.33 
Mean 0.27 0.26 -0.17 -0.20 
SD 0.20 0.13 0.31 0.15 
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F.7. Glutathione Data Tables 
Table D.7.1. Resting GSH 
Resting total GSH (µmol·L-1) 
 Basal Pre-ER 
Subject # Placebo Treatment Placebo Treatment 
111 1075.48 1067.47 1056.01 1017.79 
112 897.77 859.24 834.55 729.00 
114 1160.01 1204.47 908.83 964.60 
115 847.97 799.11 709.57 831.58 
116 477.78 1020.18 399.84 893.43 
117 1106.66 1078.21 1058.09 1079.61 
118 1261.41 1138.73 868.17 1143.04 
119 1174.25 994.06 1103.69 1174.16 
Mean 1000.17 1020.19 867.34 979.15 
SD 252.89 135.79 231.17 155.10 
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Table F.7.2. Resting GSSG 
Resting GSSG (µmol·L-1) 
 Basal Pre-ER 
Subject # Placebo Treatment Placebo Treatment 
111 329.20 265.56 384.02 270.60 
112 264.49 264.87 250.61 255.20 
114 328.48 330.80 280.93 289.34 
115 346.11 479.15 312.64 409.65 
116 252.39 268.67 122.63 236.36 
117 289.81 300.64 293.75 284.94 
118 344.71 305.95 284.42 321.74 
119 277.54 277.92 263.21 268.86 
Mean 304.09 311.69 274.03 292.09 
SD 37.40 71.59 73.41 53.76 
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Table F.7.3. Resting GSH:GSSG 
Resting GSH:GSSG 
 Basal Pre-Endurance Ride 
Subject # Placebo Treatment Placebo Treatment 
111 1.27 2.02 0.75 1.76 
112 1.39 1.24 1.33 0.86 
114 1.53 1.64 1.24 1.33 
115 0.45 -0.33 0.27 0.03 
116 -0.11 1.80 1.26 1.78 
117 1.82 1.59 1.60 1.79 
118 1.66 1.72 1.08 1.55 
119 2.23 1.58 2.19 2.37 
Mean 1.28 1.41 1.22 1.43 
SD 0.76 0.74 0.57 0.71 
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Table F.7.4. Exercising GSH 
Exercising total GSH (µmol·L-1) 
 Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 917.73 968.13 885.13 980.03 
112 781.51 878.82 759.15 629.33 
114 1184.89 1071.69 1173.67 1059.01 
115 739.37 761.69 719.82 755.02 
116 838.56 987.88 798.37 854.48 
117 1158.05 1086.85 966.82 929.64 
118 1221.92 1014.20 1216.61 1041.00 
119 927.11 855.31 849.72 839.85 
Mean 971.14 953.07 921.16 886.04 
SD 191.07 112.66 185.71 146.81 
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Table F.7.5. Exercising GSSG 
Exercising GSSG (µmol·L-1) 
 Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 350.75 245.81 437.85 252.53 
112 210.02 299.69 211.59 231.62 
114 348.99 311.80 350.16 312.15 
115 318.21 429.67 337.40 407.88 
116 161.54 263.01 213.56 249.18 
117 306.87 285.57 287.76 278.57 
118 377.69 279.67 396.33 347.86 
119 316.60 228.45 408.46 258.24 
Mean 298.83 292.96 330.39 292.25 
SD 74.57 61.65 86.20 60.13 
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Table F.7.6. Exercising GSH:GSSG 
Exercising GSH:GSSG 
 Endurance Ride Time Trial 
Subject # Placebo Treatment Placebo Treatment 
111 0.62 1.94 0.02 1.88 
112 1.72 0.93 1.59 0.72 
114 1.40 1.44 1.35 1.39 
115 0.32 -0.23 0.13 -0.15 
116 3.19 1.76 1.74 1.43 
117 1.77 1.81 1.36 1.34 
118 1.24 1.63 1.06 0.99 
119 0.93 1.74 0.08 1.25 
Mean 1.40 1.38 0.92 1.11 
SD 0.88 0.72 0.72 0.61 
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F.8. Nitrotyrosine Data Table 
Nitrotyrosine (nmol·L-1) 
 Pre-ER Post-TT 
Subject # Placebo Treatment Placebo Treatment 
111 53.20 40.92 53.15 43.28 
112 1.33 5.63 2.83 3.06 
114 30.16 22.95 27.26 27.43 
115 33.03 44.97 38.50 55.50 
116 47.99 51.65 1.34 1.03 
117 33.86 30.19 38.08 39.05 
118 178.81 211.99 424.06 352.74 
119 5.57 4.89 3.84 4.31 
Mean 47.99 51.65 73.63 65.80 




F.9. Dietary Consumption Data Table 
 Calories (kcal) Carbohydrate (g) Fat (g) Protein (g) 
Subject 
# Placebo Treatment Placebo Treatment Placebo Treatment Placebo Treatment 
111 3967.76 3968.76 603.06 603.06 132.28 132.28 90.41 90.41 
112 2714.89 2762.20 309.64 312.62 104.61 111.63 136.64 129.23 
114 4337.41 4310.55 437.94 429.33 207.37 194.04 198.96 219.96 
115 3473.94 3355.32 427.85 456.73 119.48 129.16 117.88 103.07 
116 5348.31 5310.28 701.37 731.23 199.10 197.55 183.24 176.28 
117 2413.65 2421.39 288.88 290.22 104.47 97.17 70.87 105.47 
118 3309.64 3303.37 513.77 503.32 102.64 99.43 105.49 103.09 
119 1893.26 1824.46 218.57 211.87 75.87 60.04 87.00 80.29 
Mean 3432.36 3407.04 437.64 442.30 130.73 127.66 123.81 125.98 
SD 1115.78 1112.24 164.45 171.74 47.58 47.62 46.27 48.10 
  
